JP6969037B2 - Alcohol-containing O / W emulsion and its manufacturing method - Google Patents
Alcohol-containing O / W emulsion and its manufacturing method Download PDFInfo
- Publication number
- JP6969037B2 JP6969037B2 JP2019144069A JP2019144069A JP6969037B2 JP 6969037 B2 JP6969037 B2 JP 6969037B2 JP 2019144069 A JP2019144069 A JP 2019144069A JP 2019144069 A JP2019144069 A JP 2019144069A JP 6969037 B2 JP6969037 B2 JP 6969037B2
- Authority
- JP
- Japan
- Prior art keywords
- alcohol
- type emulsion
- acid
- acid ester
- emulsion
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 239000000839 emulsion Substances 0.000 title claims description 194
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 title claims description 191
- 238000004519 manufacturing process Methods 0.000 title claims description 11
- -1 fatty acid ester Chemical class 0.000 claims description 96
- 235000014113 dietary fatty acids Nutrition 0.000 claims description 88
- 239000000194 fatty acid Substances 0.000 claims description 88
- 229930195729 fatty acid Natural products 0.000 claims description 88
- 239000008346 aqueous phase Substances 0.000 claims description 76
- 239000012071 phase Substances 0.000 claims description 50
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 claims description 31
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 claims description 19
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 claims description 17
- 239000002537 cosmetic Substances 0.000 claims description 16
- 150000004665 fatty acids Chemical class 0.000 claims description 15
- 235000013305 food Nutrition 0.000 claims description 15
- 239000000126 substance Substances 0.000 claims description 15
- 238000003756 stirring Methods 0.000 claims description 14
- 150000001298 alcohols Chemical class 0.000 claims description 13
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 claims description 12
- 125000004432 carbon atom Chemical group C* 0.000 claims description 10
- 150000005846 sugar alcohols Polymers 0.000 claims description 10
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 claims description 9
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 claims description 9
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 claims description 9
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims description 9
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 claims description 9
- 229930003268 Vitamin C Natural products 0.000 claims description 9
- 229930003427 Vitamin E Natural products 0.000 claims description 9
- BTANRVKWQNVYAZ-UHFFFAOYSA-N butan-2-ol Chemical compound CCC(C)O BTANRVKWQNVYAZ-UHFFFAOYSA-N 0.000 claims description 9
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 claims description 9
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 claims description 9
- 239000003002 pH adjusting agent Substances 0.000 claims description 9
- 150000008442 polyphenolic compounds Chemical class 0.000 claims description 9
- 235000013824 polyphenols Nutrition 0.000 claims description 9
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 claims description 9
- 235000019154 vitamin C Nutrition 0.000 claims description 9
- 239000011718 vitamin C Substances 0.000 claims description 9
- 235000019165 vitamin E Nutrition 0.000 claims description 9
- 229940046009 vitamin E Drugs 0.000 claims description 9
- 239000011709 vitamin E Substances 0.000 claims description 9
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 claims description 8
- 239000011734 sodium Substances 0.000 claims description 7
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 claims description 6
- RGHNJXZEOKUKBD-SQOUGZDYSA-N D-gluconic acid Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O RGHNJXZEOKUKBD-SQOUGZDYSA-N 0.000 claims description 6
- VZCYOOQTPOCHFL-OWOJBTEDSA-N Fumaric acid Chemical compound OC(=O)\C=C\C(O)=O VZCYOOQTPOCHFL-OWOJBTEDSA-N 0.000 claims description 6
- AEMRFAOFKBGASW-UHFFFAOYSA-N Glycolic acid Chemical compound OCC(O)=O AEMRFAOFKBGASW-UHFFFAOYSA-N 0.000 claims description 6
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 claims description 6
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 claims description 6
- KDYFGRWQOYBRFD-UHFFFAOYSA-N Succinic acid Natural products OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 claims description 6
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 claims description 6
- WNLRTRBMVRJNCN-UHFFFAOYSA-N adipic acid Chemical compound OC(=O)CCCCC(O)=O WNLRTRBMVRJNCN-UHFFFAOYSA-N 0.000 claims description 6
- KDYFGRWQOYBRFD-NUQCWPJISA-N butanedioic acid Chemical compound O[14C](=O)CC[14C](O)=O KDYFGRWQOYBRFD-NUQCWPJISA-N 0.000 claims description 6
- 230000001804 emulsifying effect Effects 0.000 claims description 6
- ZXEKIIBDNHEJCQ-UHFFFAOYSA-N isobutanol Chemical compound CC(C)CO ZXEKIIBDNHEJCQ-UHFFFAOYSA-N 0.000 claims description 6
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 claims description 6
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 claims description 6
- LWIHDJKSTIGBAC-UHFFFAOYSA-K tripotassium phosphate Chemical compound [K+].[K+].[K+].[O-]P([O-])([O-])=O LWIHDJKSTIGBAC-UHFFFAOYSA-K 0.000 claims description 6
- CIWBSHSKHKDKBQ-DUZGATOHSA-N D-araboascorbic acid Natural products OC[C@@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-DUZGATOHSA-N 0.000 claims description 5
- 235000010350 erythorbic acid Nutrition 0.000 claims description 5
- 239000004318 erythorbic acid Substances 0.000 claims description 5
- 229940026239 isoascorbic acid Drugs 0.000 claims description 5
- 235000000069 L-ascorbic acid Nutrition 0.000 claims description 4
- 239000002211 L-ascorbic acid Substances 0.000 claims description 4
- 229960005070 ascorbic acid Drugs 0.000 claims description 4
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 claims description 3
- AEQDJSLRWYMAQI-UHFFFAOYSA-N 2,3,9,10-tetramethoxy-6,8,13,13a-tetrahydro-5H-isoquinolino[2,1-b]isoquinoline Chemical compound C1CN2CC(C(=C(OC)C=C3)OC)=C3CC2C2=C1C=C(OC)C(OC)=C2 AEQDJSLRWYMAQI-UHFFFAOYSA-N 0.000 claims description 3
- CYDQOEWLBCCFJZ-UHFFFAOYSA-N 4-(4-fluorophenyl)oxane-4-carboxylic acid Chemical compound C=1C=C(F)C=CC=1C1(C(=O)O)CCOCC1 CYDQOEWLBCCFJZ-UHFFFAOYSA-N 0.000 claims description 3
- ATRRKUHOCOJYRX-UHFFFAOYSA-N Ammonium bicarbonate Chemical compound [NH4+].OC([O-])=O ATRRKUHOCOJYRX-UHFFFAOYSA-N 0.000 claims description 3
- RGHNJXZEOKUKBD-UHFFFAOYSA-N D-gluconic acid Natural products OCC(O)C(O)C(O)C(O)C(O)=O RGHNJXZEOKUKBD-UHFFFAOYSA-N 0.000 claims description 3
- PHOQVHQSTUBQQK-SQOUGZDYSA-N D-glucono-1,5-lactone Chemical compound OC[C@H]1OC(=O)[C@H](O)[C@@H](O)[C@@H]1O PHOQVHQSTUBQQK-SQOUGZDYSA-N 0.000 claims description 3
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 claims description 3
- 229910002651 NO3 Inorganic materials 0.000 claims description 3
- NHNBFGGVMKEFGY-UHFFFAOYSA-N Nitrate Chemical compound [O-][N+]([O-])=O NHNBFGGVMKEFGY-UHFFFAOYSA-N 0.000 claims description 3
- HLCFGWHYROZGBI-JJKGCWMISA-M Potassium gluconate Chemical compound [K+].OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O HLCFGWHYROZGBI-JJKGCWMISA-M 0.000 claims description 3
- VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 claims description 3
- 239000001361 adipic acid Substances 0.000 claims description 3
- 235000011037 adipic acid Nutrition 0.000 claims description 3
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 claims description 3
- 229910000147 aluminium phosphate Inorganic materials 0.000 claims description 3
- 229910021529 ammonia Inorganic materials 0.000 claims description 3
- 239000001099 ammonium carbonate Substances 0.000 claims description 3
- 235000012501 ammonium carbonate Nutrition 0.000 claims description 3
- AXCZMVOFGPJBDE-UHFFFAOYSA-L calcium dihydroxide Chemical compound [OH-].[OH-].[Ca+2] AXCZMVOFGPJBDE-UHFFFAOYSA-L 0.000 claims description 3
- 239000000920 calcium hydroxide Substances 0.000 claims description 3
- 229910001861 calcium hydroxide Inorganic materials 0.000 claims description 3
- 235000015165 citric acid Nutrition 0.000 claims description 3
- 239000000084 colloidal system Substances 0.000 claims description 3
- XPPKVPWEQAFLFU-UHFFFAOYSA-J diphosphate(4-) Chemical compound [O-]P([O-])(=O)OP([O-])([O-])=O XPPKVPWEQAFLFU-UHFFFAOYSA-J 0.000 claims description 3
- 235000011180 diphosphates Nutrition 0.000 claims description 3
- 230000005686 electrostatic field Effects 0.000 claims description 3
- 239000001530 fumaric acid Substances 0.000 claims description 3
- 239000000174 gluconic acid Substances 0.000 claims description 3
- 235000012208 gluconic acid Nutrition 0.000 claims description 3
- 235000012209 glucono delta-lactone Nutrition 0.000 claims description 3
- 239000000182 glucono-delta-lactone Substances 0.000 claims description 3
- 229960003681 gluconolactone Drugs 0.000 claims description 3
- 239000004310 lactic acid Substances 0.000 claims description 3
- 235000014655 lactic acid Nutrition 0.000 claims description 3
- VTHJTEIRLNZDEV-UHFFFAOYSA-L magnesium dihydroxide Chemical compound [OH-].[OH-].[Mg+2] VTHJTEIRLNZDEV-UHFFFAOYSA-L 0.000 claims description 3
- 239000000347 magnesium hydroxide Substances 0.000 claims description 3
- 229910001862 magnesium hydroxide Inorganic materials 0.000 claims description 3
- 239000001630 malic acid Substances 0.000 claims description 3
- 235000011090 malic acid Nutrition 0.000 claims description 3
- 239000005373 porous glass Substances 0.000 claims description 3
- 229910000027 potassium carbonate Inorganic materials 0.000 claims description 3
- 239000004224 potassium gluconate Substances 0.000 claims description 3
- 235000013926 potassium gluconate Nutrition 0.000 claims description 3
- 229960003189 potassium gluconate Drugs 0.000 claims description 3
- 229910000160 potassium phosphate Inorganic materials 0.000 claims description 3
- 235000011009 potassium phosphates Nutrition 0.000 claims description 3
- 239000001632 sodium acetate Substances 0.000 claims description 3
- 235000017281 sodium acetate Nutrition 0.000 claims description 3
- 229910000029 sodium carbonate Inorganic materials 0.000 claims description 3
- 239000001509 sodium citrate Substances 0.000 claims description 3
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 claims description 3
- 235000011083 sodium citrates Nutrition 0.000 claims description 3
- 239000000176 sodium gluconate Substances 0.000 claims description 3
- 235000012207 sodium gluconate Nutrition 0.000 claims description 3
- 229940005574 sodium gluconate Drugs 0.000 claims description 3
- 239000001540 sodium lactate Substances 0.000 claims description 3
- 235000011088 sodium lactate Nutrition 0.000 claims description 3
- 229940005581 sodium lactate Drugs 0.000 claims description 3
- 239000001488 sodium phosphate Substances 0.000 claims description 3
- 229910000162 sodium phosphate Inorganic materials 0.000 claims description 3
- 235000011008 sodium phosphates Nutrition 0.000 claims description 3
- 229940074404 sodium succinate Drugs 0.000 claims description 3
- ZDQYSKICYIVCPN-UHFFFAOYSA-L sodium succinate (anhydrous) Chemical compound [Na+].[Na+].[O-]C(=O)CCC([O-])=O ZDQYSKICYIVCPN-UHFFFAOYSA-L 0.000 claims description 3
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 claims description 3
- RYFMWSXOAZQYPI-UHFFFAOYSA-K trisodium phosphate Chemical compound [Na+].[Na+].[Na+].[O-]P([O-])([O-])=O RYFMWSXOAZQYPI-UHFFFAOYSA-K 0.000 claims description 3
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 claims description 2
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 claims description 2
- 235000011007 phosphoric acid Nutrition 0.000 claims description 2
- 125000004402 polyphenol group Chemical group 0.000 claims description 2
- 235000015424 sodium Nutrition 0.000 claims description 2
- 229910052708 sodium Inorganic materials 0.000 claims description 2
- PPASLZSBLFJQEF-RKJRWTFHSA-M sodium ascorbate Substances [Na+].OC[C@@H](O)[C@H]1OC(=O)C(O)=C1[O-] PPASLZSBLFJQEF-RKJRWTFHSA-M 0.000 claims description 2
- 229960005055 sodium ascorbate Drugs 0.000 claims description 2
- 229940048086 sodium pyrophosphate Drugs 0.000 claims description 2
- PPASLZSBLFJQEF-RXSVEWSESA-M sodium-L-ascorbate Chemical compound [Na+].OC[C@H](O)[C@H]1OC(=O)C(O)=C1[O-] PPASLZSBLFJQEF-RXSVEWSESA-M 0.000 claims description 2
- 239000011975 tartaric acid Substances 0.000 claims description 2
- 235000002906 tartaric acid Nutrition 0.000 claims description 2
- 239000000825 pharmaceutical preparation Substances 0.000 claims 1
- 229940127557 pharmaceutical product Drugs 0.000 claims 1
- 235000010378 sodium ascorbate Nutrition 0.000 claims 1
- 239000003921 oil Substances 0.000 description 84
- 235000019198 oils Nutrition 0.000 description 84
- 235000020083 shōchū Nutrition 0.000 description 67
- 239000000243 solution Substances 0.000 description 59
- 239000005288 shirasu porous glass Substances 0.000 description 43
- 239000000203 mixture Substances 0.000 description 39
- 239000011259 mixed solution Substances 0.000 description 31
- 239000002245 particle Substances 0.000 description 29
- 238000011156 evaluation Methods 0.000 description 27
- 239000007788 liquid Substances 0.000 description 19
- 239000002253 acid Substances 0.000 description 18
- 238000004945 emulsification Methods 0.000 description 17
- 239000003995 emulsifying agent Substances 0.000 description 17
- 150000002148 esters Chemical class 0.000 description 17
- 239000012528 membrane Substances 0.000 description 15
- 239000003795 chemical substances by application Substances 0.000 description 12
- 238000010979 pH adjustment Methods 0.000 description 12
- 239000008194 pharmaceutical composition Substances 0.000 description 12
- 239000002904 solvent Substances 0.000 description 11
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 11
- 239000004094 surface-active agent Substances 0.000 description 10
- 240000008415 Lactuca sativa Species 0.000 description 9
- 239000006185 dispersion Substances 0.000 description 9
- 235000021323 fish oil Nutrition 0.000 description 9
- 238000002360 preparation method Methods 0.000 description 9
- 235000012045 salad Nutrition 0.000 description 9
- 102000004190 Enzymes Human genes 0.000 description 8
- 108090000790 Enzymes Proteins 0.000 description 8
- 230000001953 sensory effect Effects 0.000 description 8
- 230000000007 visual effect Effects 0.000 description 8
- 235000013334 alcoholic beverage Nutrition 0.000 description 7
- 239000000796 flavoring agent Substances 0.000 description 7
- 235000019634 flavors Nutrition 0.000 description 7
- 239000008363 phosphate buffer Substances 0.000 description 7
- OENHQHLEOONYIE-UKMVMLAPSA-N all-trans beta-carotene Natural products CC=1CCCC(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C OENHQHLEOONYIE-UKMVMLAPSA-N 0.000 description 5
- 235000013734 beta-carotene Nutrition 0.000 description 5
- 239000011648 beta-carotene Substances 0.000 description 5
- TUPZEYHYWIEDIH-WAIFQNFQSA-N beta-carotene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C)C=CC=C(/C)C=CC2=CCCCC2(C)C TUPZEYHYWIEDIH-WAIFQNFQSA-N 0.000 description 5
- 229960002747 betacarotene Drugs 0.000 description 5
- 239000006071 cream Substances 0.000 description 5
- 230000000694 effects Effects 0.000 description 5
- 238000005259 measurement Methods 0.000 description 5
- 238000000879 optical micrograph Methods 0.000 description 5
- 239000011148 porous material Substances 0.000 description 5
- OENHQHLEOONYIE-JLTXGRSLSA-N β-Carotene Chemical compound CC=1CCCC(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C OENHQHLEOONYIE-JLTXGRSLSA-N 0.000 description 5
- 239000012556 adjustment buffer Substances 0.000 description 4
- 238000005516 engineering process Methods 0.000 description 4
- MMXKVMNBHPAILY-UHFFFAOYSA-N ethyl laurate Chemical compound CCCCCCCCCCCC(=O)OCC MMXKVMNBHPAILY-UHFFFAOYSA-N 0.000 description 4
- MMKRHZKQPFCLLS-UHFFFAOYSA-N ethyl myristate Chemical compound CCCCCCCCCCCCCC(=O)OCC MMKRHZKQPFCLLS-UHFFFAOYSA-N 0.000 description 4
- MVLVMROFTAUDAG-UHFFFAOYSA-N ethyl octadecanoate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC MVLVMROFTAUDAG-UHFFFAOYSA-N 0.000 description 4
- 239000003960 organic solvent Substances 0.000 description 4
- 235000019640 taste Nutrition 0.000 description 4
- 230000008719 thickening Effects 0.000 description 4
- 235000021122 unsaturated fatty acids Nutrition 0.000 description 4
- 235000010208 anthocyanin Nutrition 0.000 description 3
- 239000004410 anthocyanin Substances 0.000 description 3
- 229930002877 anthocyanin Natural products 0.000 description 3
- 150000004636 anthocyanins Chemical class 0.000 description 3
- 239000000872 buffer Substances 0.000 description 3
- 239000002775 capsule Substances 0.000 description 3
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 3
- 230000003779 hair growth Effects 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- 238000000034 method Methods 0.000 description 3
- 230000003647 oxidation Effects 0.000 description 3
- 238000007254 oxidation reaction Methods 0.000 description 3
- 235000000346 sugar Nutrition 0.000 description 3
- 238000011179 visual inspection Methods 0.000 description 3
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- 235000021294 Docosapentaenoic acid Nutrition 0.000 description 2
- LVGKNOAMLMIIKO-UHFFFAOYSA-N Elaidinsaeure-aethylester Natural products CCCCCCCCC=CCCCCCCCC(=O)OCC LVGKNOAMLMIIKO-UHFFFAOYSA-N 0.000 description 2
- 239000004909 Moisturizer Substances 0.000 description 2
- 241000745768 Pluchea carolinensis Species 0.000 description 2
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- 230000003796 beauty Effects 0.000 description 2
- 239000007853 buffer solution Substances 0.000 description 2
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 2
- 239000004359 castor oil Substances 0.000 description 2
- 235000019438 castor oil Nutrition 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- VFLDPWHFBUODDF-FCXRPNKRSA-N curcumin Chemical compound C1=C(O)C(OC)=CC(\C=C\C(=O)CC(=O)\C=C\C=2C=C(OC)C(O)=CC=2)=C1 VFLDPWHFBUODDF-FCXRPNKRSA-N 0.000 description 2
- 125000003450 decanoic acid ester group Chemical group 0.000 description 2
- 229910001873 dinitrogen Inorganic materials 0.000 description 2
- 238000004090 dissolution Methods 0.000 description 2
- 238000009826 distribution Methods 0.000 description 2
- RGXWDWUGBIJHDO-UHFFFAOYSA-N ethyl decanoate Chemical compound CCCCCCCCCC(=O)OCC RGXWDWUGBIJHDO-UHFFFAOYSA-N 0.000 description 2
- FMMOOAYVCKXGMF-MURFETPASA-N ethyl linoleate Chemical compound CCCCC\C=C/C\C=C/CCCCCCCC(=O)OCC FMMOOAYVCKXGMF-MURFETPASA-N 0.000 description 2
- 229940031016 ethyl linoleate Drugs 0.000 description 2
- JYYFMIOPGOFNPK-AGRJPVHOSA-N ethyl linolenate Chemical compound CCOC(=O)CCCCCCC\C=C/C\C=C/C\C=C/CC JYYFMIOPGOFNPK-AGRJPVHOSA-N 0.000 description 2
- LVGKNOAMLMIIKO-QXMHVHEDSA-N ethyl oleate Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OCC LVGKNOAMLMIIKO-QXMHVHEDSA-N 0.000 description 2
- 229940093471 ethyl oleate Drugs 0.000 description 2
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 2
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 2
- 230000006872 improvement Effects 0.000 description 2
- 239000010410 layer Substances 0.000 description 2
- FMMOOAYVCKXGMF-UHFFFAOYSA-N linoleic acid ethyl ester Natural products CCCCCC=CCC=CCCCCCCCC(=O)OCC FMMOOAYVCKXGMF-UHFFFAOYSA-N 0.000 description 2
- 150000002632 lipids Chemical class 0.000 description 2
- 235000020094 liqueur Nutrition 0.000 description 2
- 239000006210 lotion Substances 0.000 description 2
- 238000012423 maintenance Methods 0.000 description 2
- BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 description 2
- 230000001333 moisturizer Effects 0.000 description 2
- 239000002674 ointment Substances 0.000 description 2
- 230000003287 optical effect Effects 0.000 description 2
- 230000000704 physical effect Effects 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 238000010008 shearing Methods 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 235000015096 spirit Nutrition 0.000 description 2
- 150000008163 sugars Chemical class 0.000 description 2
- 235000013619 trace mineral Nutrition 0.000 description 2
- 239000011573 trace mineral Substances 0.000 description 2
- QAIPRVGONGVQAS-DUXPYHPUSA-N trans-caffeic acid Chemical compound OC(=O)\C=C\C1=CC=C(O)C(O)=C1 QAIPRVGONGVQAS-DUXPYHPUSA-N 0.000 description 2
- 150000004670 unsaturated fatty acids Chemical class 0.000 description 2
- 229940088594 vitamin Drugs 0.000 description 2
- 229930003231 vitamin Natural products 0.000 description 2
- 235000013343 vitamin Nutrition 0.000 description 2
- 239000011782 vitamin Substances 0.000 description 2
- PFTAWBLQPZVEMU-DZGCQCFKSA-N (+)-catechin Chemical compound C1([C@H]2OC3=CC(O)=CC(O)=C3C[C@@H]2O)=CC=C(O)C(O)=C1 PFTAWBLQPZVEMU-DZGCQCFKSA-N 0.000 description 1
- GWHCXVQVJPWHRF-KTKRTIGZSA-N (15Z)-tetracosenoic acid Chemical class CCCCCCCC\C=C/CCCCCCCCCCCCCC(O)=O GWHCXVQVJPWHRF-KTKRTIGZSA-N 0.000 description 1
- HOBAELRKJCKHQD-UHFFFAOYSA-N (8Z,11Z,14Z)-8,11,14-eicosatrienoic acid Natural products CCCCCC=CCC=CCC=CCCCCCCC(O)=O HOBAELRKJCKHQD-UHFFFAOYSA-N 0.000 description 1
- ACEAELOMUCBPJP-UHFFFAOYSA-N (E)-3,4,5-trihydroxycinnamic acid Natural products OC(=O)C=CC1=CC(O)=C(O)C(O)=C1 ACEAELOMUCBPJP-UHFFFAOYSA-N 0.000 description 1
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 description 1
- SECPZKHBENQXJG-FPLPWBNLSA-N (Z)-Palmitoleic acid Natural products CCCCCC\C=C/CCCCCCCC(O)=O SECPZKHBENQXJG-FPLPWBNLSA-N 0.000 description 1
- DTOSIQBPPRVQHS-PDBXOOCHSA-N (Z,Z,Z)-Octadeca-9,12,15-trienoic acid Natural products CC\C=C/C\C=C/C\C=C/CCCCCCCC(O)=O DTOSIQBPPRVQHS-PDBXOOCHSA-N 0.000 description 1
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 description 1
- CWVRJTMFETXNAD-FWCWNIRPSA-N 3-O-Caffeoylquinic acid Natural products O[C@H]1[C@@H](O)C[C@@](O)(C(O)=O)C[C@H]1OC(=O)\C=C\C1=CC=C(O)C(O)=C1 CWVRJTMFETXNAD-FWCWNIRPSA-N 0.000 description 1
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 description 1
- JMGZEFIQIZZSBH-UHFFFAOYSA-N Bioquercetin Natural products CC1OC(OCC(O)C2OC(OC3=C(Oc4cc(O)cc(O)c4C3=O)c5ccc(O)c(O)c5)C(O)C2O)C(O)C(O)C1O JMGZEFIQIZZSBH-UHFFFAOYSA-N 0.000 description 1
- PZIRUHCJZBGLDY-UHFFFAOYSA-N Caffeoylquinic acid Natural products CC(CCC(=O)C(C)C1C(=O)CC2C3CC(O)C4CC(O)CCC4(C)C3CCC12C)C(=O)O PZIRUHCJZBGLDY-UHFFFAOYSA-N 0.000 description 1
- 239000004215 Carbon black (E152) Substances 0.000 description 1
- 235000021298 Dihomo-γ-linolenic acid Nutrition 0.000 description 1
- 239000004278 EU approved seasoning Substances 0.000 description 1
- AFSDNFLWKVMVRB-UHFFFAOYSA-N Ellagic acid Chemical class OC1=C(O)C(OC2=O)=C3C4=C2C=C(O)C(O)=C4OC(=O)C3=C1 AFSDNFLWKVMVRB-UHFFFAOYSA-N 0.000 description 1
- 240000008620 Fagopyrum esculentum Species 0.000 description 1
- 235000009419 Fagopyrum esculentum Nutrition 0.000 description 1
- 240000005979 Hordeum vulgare Species 0.000 description 1
- 235000007340 Hordeum vulgare Nutrition 0.000 description 1
- 244000017020 Ipomoea batatas Species 0.000 description 1
- 235000002678 Ipomoea batatas Nutrition 0.000 description 1
- 235000021353 Lignoceric acid Nutrition 0.000 description 1
- CQXMAMUUWHYSIY-UHFFFAOYSA-N Lignoceric acid Natural products CCCCCCCCCCCCCCCCCCCCCCCC(=O)OCCC1=CC=C(O)C=C1 CQXMAMUUWHYSIY-UHFFFAOYSA-N 0.000 description 1
- 239000004367 Lipase Substances 0.000 description 1
- 102000004882 Lipase Human genes 0.000 description 1
- 108090001060 Lipase Proteins 0.000 description 1
- 244000294411 Mirabilis expansa Species 0.000 description 1
- 235000015429 Mirabilis expansa Nutrition 0.000 description 1
- 235000021360 Myristic acid Nutrition 0.000 description 1
- TUNFSRHWOTWDNC-UHFFFAOYSA-N Myristic acid Natural products CCCCCCCCCCCCCC(O)=O TUNFSRHWOTWDNC-UHFFFAOYSA-N 0.000 description 1
- CWVRJTMFETXNAD-KLZCAUPSSA-N Neochlorogenin-saeure Natural products O[C@H]1C[C@@](O)(C[C@@H](OC(=O)C=Cc2ccc(O)c(O)c2)[C@@H]1O)C(=O)O CWVRJTMFETXNAD-KLZCAUPSSA-N 0.000 description 1
- 239000005642 Oleic acid Substances 0.000 description 1
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 description 1
- 240000007594 Oryza sativa Species 0.000 description 1
- 235000007164 Oryza sativa Nutrition 0.000 description 1
- 235000021314 Palmitic acid Nutrition 0.000 description 1
- 235000021319 Palmitoleic acid Nutrition 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- 244000061456 Solanum tuberosum Species 0.000 description 1
- 235000002595 Solanum tuberosum Nutrition 0.000 description 1
- 239000008351 acetate buffer Substances 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 125000003158 alcohol group Chemical group 0.000 description 1
- 235000020661 alpha-linolenic acid Nutrition 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 235000021342 arachidonic acid Nutrition 0.000 description 1
- 229940114079 arachidonic acid Drugs 0.000 description 1
- YZXBAPSDXZZRGB-DOFZRALJSA-N arachidonic acid Natural products CCCCC\C=C/C\C=C/C\C=C/C\C=C/CCCC(O)=O YZXBAPSDXZZRGB-DOFZRALJSA-N 0.000 description 1
- 235000019606 astringent taste Nutrition 0.000 description 1
- 239000013040 bath agent Substances 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 150000001656 butanoic acid esters Chemical class 0.000 description 1
- 235000004883 caffeic acid Nutrition 0.000 description 1
- 229940074360 caffeic acid Drugs 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-N carbonic acid Chemical compound OC(O)=O BVKZGUZCCUSVTD-UHFFFAOYSA-N 0.000 description 1
- 150000001732 carboxylic acid derivatives Chemical class 0.000 description 1
- ADRVNXBAWSRFAJ-UHFFFAOYSA-N catechin Natural products OC1Cc2cc(O)cc(O)c2OC1c3ccc(O)c(O)c3 ADRVNXBAWSRFAJ-UHFFFAOYSA-N 0.000 description 1
- 235000005487 catechin Nutrition 0.000 description 1
- 235000013339 cereals Nutrition 0.000 description 1
- CWVRJTMFETXNAD-JUHZACGLSA-N chlorogenic acid Chemical compound O[C@@H]1[C@H](O)C[C@@](O)(C(O)=O)C[C@H]1OC(=O)\C=C\C1=CC=C(O)C(O)=C1 CWVRJTMFETXNAD-JUHZACGLSA-N 0.000 description 1
- 229940074393 chlorogenic acid Drugs 0.000 description 1
- 235000001368 chlorogenic acid Nutrition 0.000 description 1
- FFQSDFBBSXGVKF-KHSQJDLVSA-N chlorogenic acid Natural products O[C@@H]1C[C@](O)(C[C@@H](CC(=O)C=Cc2ccc(O)c(O)c2)[C@@H]1O)C(=O)O FFQSDFBBSXGVKF-KHSQJDLVSA-N 0.000 description 1
- 229950001002 cianidanol Drugs 0.000 description 1
- BMRSEYFENKXDIS-KLZCAUPSSA-N cis-3-O-p-coumaroylquinic acid Natural products O[C@H]1C[C@@](O)(C[C@@H](OC(=O)C=Cc2ccc(O)cc2)[C@@H]1O)C(=O)O BMRSEYFENKXDIS-KLZCAUPSSA-N 0.000 description 1
- QAIPRVGONGVQAS-UHFFFAOYSA-N cis-caffeic acid Natural products OC(=O)C=CC1=CC=C(O)C(O)=C1 QAIPRVGONGVQAS-UHFFFAOYSA-N 0.000 description 1
- SECPZKHBENQXJG-UHFFFAOYSA-N cis-palmitoleic acid Natural products CCCCCCC=CCCCCCCCC(O)=O SECPZKHBENQXJG-UHFFFAOYSA-N 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 239000002285 corn oil Substances 0.000 description 1
- 235000005687 corn oil Nutrition 0.000 description 1
- 235000012754 curcumin Nutrition 0.000 description 1
- 239000004148 curcumin Substances 0.000 description 1
- 229940109262 curcumin Drugs 0.000 description 1
- CYQFCXCEBYINGO-IAGOWNOFSA-N delta1-THC Chemical compound C1=C(C)CC[C@H]2C(C)(C)OC3=CC(CCCCC)=CC(O)=C3[C@@H]21 CYQFCXCEBYINGO-IAGOWNOFSA-N 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 235000015872 dietary supplement Nutrition 0.000 description 1
- VFLDPWHFBUODDF-UHFFFAOYSA-N diferuloylmethane Natural products C1=C(O)C(OC)=CC(C=CC(=O)CC(=O)C=CC=2C=C(OC)C(O)=CC=2)=C1 VFLDPWHFBUODDF-UHFFFAOYSA-N 0.000 description 1
- MBMBGCFOFBJSGT-KUBAVDMBSA-N docosahexaenoic acid Natural products CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCC(O)=O MBMBGCFOFBJSGT-KUBAVDMBSA-N 0.000 description 1
- 235000020669 docosahexaenoic acid Nutrition 0.000 description 1
- 229940090949 docosahexaenoic acid Drugs 0.000 description 1
- 235000015071 dressings Nutrition 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- IVTMALDHFAHOGL-UHFFFAOYSA-N eriodictyol 7-O-rutinoside Natural products OC1C(O)C(O)C(C)OC1OCC1C(O)C(O)C(O)C(OC=2C=C3C(C(C(O)=C(O3)C=3C=C(O)C(O)=CC=3)=O)=C(O)C=2)O1 IVTMALDHFAHOGL-UHFFFAOYSA-N 0.000 description 1
- DPUOLQHDNGRHBS-KTKRTIGZSA-N erucic acid Chemical class CCCCCCCC\C=C/CCCCCCCCCCCC(O)=O DPUOLQHDNGRHBS-KTKRTIGZSA-N 0.000 description 1
- 239000000686 essence Substances 0.000 description 1
- 150000002168 ethanoic acid esters Chemical class 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 230000001815 facial effect Effects 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 239000010419 fine particle Substances 0.000 description 1
- 235000011194 food seasoning agent Nutrition 0.000 description 1
- 235000019253 formic acid Nutrition 0.000 description 1
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 1
- 235000013376 functional food Nutrition 0.000 description 1
- VZCCETWTMQHEPK-UHFFFAOYSA-N gamma-Linolensaeure Natural products CCCCCC=CCC=CCC=CCCCCC(O)=O VZCCETWTMQHEPK-UHFFFAOYSA-N 0.000 description 1
- 235000020664 gamma-linolenic acid Nutrition 0.000 description 1
- 229960002733 gamolenic acid Drugs 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 150000002334 glycols Chemical class 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- MNWFXJYAOYHMED-UHFFFAOYSA-M heptanoate Chemical compound CCCCCCC([O-])=O MNWFXJYAOYHMED-UHFFFAOYSA-M 0.000 description 1
- 150000002400 hexanoic acid esters Chemical class 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 229930195733 hydrocarbon Natural products 0.000 description 1
- 150000002430 hydrocarbons Chemical class 0.000 description 1
- 239000002440 industrial waste Substances 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- GOMNOOKGLZYEJT-UHFFFAOYSA-N isoflavone Chemical compound C=1OC2=CC=CC=C2C(=O)C=1C1=CC=CC=C1 GOMNOOKGLZYEJT-UHFFFAOYSA-N 0.000 description 1
- CJWQYWQDLBZGPD-UHFFFAOYSA-N isoflavone Natural products C1=C(OC)C(OC)=CC(OC)=C1C1=COC2=C(C=CC(C)(C)O3)C3=C(OC)C=C2C1=O CJWQYWQDLBZGPD-UHFFFAOYSA-N 0.000 description 1
- 235000008696 isoflavones Nutrition 0.000 description 1
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 description 1
- 150000002576 ketones Chemical class 0.000 description 1
- VMPHSYLJUKZBJJ-UHFFFAOYSA-N lauric acid triglyceride Natural products CCCCCCCCCCCC(=O)OCC(OC(=O)CCCCCCCCCCC)COC(=O)CCCCCCCCCCC VMPHSYLJUKZBJJ-UHFFFAOYSA-N 0.000 description 1
- 229960004488 linolenic acid Drugs 0.000 description 1
- 235000019421 lipase Nutrition 0.000 description 1
- 150000004668 long chain fatty acids Chemical class 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 150000004667 medium chain fatty acids Chemical class 0.000 description 1
- 235000013536 miso Nutrition 0.000 description 1
- 235000021281 monounsaturated fatty acids Nutrition 0.000 description 1
- WQEPLUUGTLDZJY-UHFFFAOYSA-N n-Pentadecanoic acid Natural products CCCCCCCCCCCCCCC(O)=O WQEPLUUGTLDZJY-UHFFFAOYSA-N 0.000 description 1
- KEMQGTRYUADPNZ-UHFFFAOYSA-N n-heptadecanoic acid Natural products CCCCCCCCCCCCCCCCC(O)=O KEMQGTRYUADPNZ-UHFFFAOYSA-N 0.000 description 1
- IPCSVZSSVZVIGE-UHFFFAOYSA-N n-hexadecanoic acid Natural products CCCCCCCCCCCCCCCC(O)=O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 description 1
- 150000002842 nonanoic acids Chemical class 0.000 description 1
- 239000002736 nonionic surfactant Substances 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 239000007764 o/w emulsion Substances 0.000 description 1
- 235000021354 omega 7 monounsaturated fatty acids Nutrition 0.000 description 1
- 235000021315 omega 9 monounsaturated fatty acids Nutrition 0.000 description 1
- 235000020660 omega-3 fatty acid Nutrition 0.000 description 1
- 229940012843 omega-3 fatty acid Drugs 0.000 description 1
- 235000020665 omega-6 fatty acid Nutrition 0.000 description 1
- 229940033080 omega-6 fatty acid Drugs 0.000 description 1
- 239000006072 paste Substances 0.000 description 1
- 125000002958 pentadecyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 150000002969 pentanoic acid esters Chemical class 0.000 description 1
- 230000002688 persistence Effects 0.000 description 1
- 238000010587 phase diagram Methods 0.000 description 1
- 239000008055 phosphate buffer solution Substances 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- 235000020777 polyunsaturated fatty acids Nutrition 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 150000003151 propanoic acid esters Chemical class 0.000 description 1
- 235000019633 pungent taste Nutrition 0.000 description 1
- 229940048084 pyrophosphate Drugs 0.000 description 1
- FDRQPMVGJOQVTL-UHFFFAOYSA-N quercetin rutinoside Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 FDRQPMVGJOQVTL-UHFFFAOYSA-N 0.000 description 1
- 235000009566 rice Nutrition 0.000 description 1
- 235000005493 rutin Nutrition 0.000 description 1
- IKGXIBQEEMLURG-BKUODXTLSA-N rutin Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@@H]1OC[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 IKGXIBQEEMLURG-BKUODXTLSA-N 0.000 description 1
- ALABRVAAKCSLSC-UHFFFAOYSA-N rutin Natural products CC1OC(OCC2OC(O)C(O)C(O)C2O)C(O)C(O)C1OC3=C(Oc4cc(O)cc(O)c4C3=O)c5ccc(O)c(O)c5 ALABRVAAKCSLSC-UHFFFAOYSA-N 0.000 description 1
- 229960004555 rutoside Drugs 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 235000003441 saturated fatty acids Nutrition 0.000 description 1
- 150000004671 saturated fatty acids Chemical class 0.000 description 1
- 235000021391 short chain fatty acids Nutrition 0.000 description 1
- 150000004666 short chain fatty acids Chemical class 0.000 description 1
- 239000004320 sodium erythorbate Substances 0.000 description 1
- 235000010352 sodium erythorbate Nutrition 0.000 description 1
- 239000011755 sodium-L-ascorbate Substances 0.000 description 1
- 235000019187 sodium-L-ascorbate Nutrition 0.000 description 1
- RBWSWDPRDBEWCR-RKJRWTFHSA-N sodium;(2r)-2-[(2r)-3,4-dihydroxy-5-oxo-2h-furan-2-yl]-2-hydroxyethanolate Chemical compound [Na+].[O-]C[C@@H](O)[C@H]1OC(=O)C(O)=C1O RBWSWDPRDBEWCR-RKJRWTFHSA-N 0.000 description 1
- 235000012424 soybean oil Nutrition 0.000 description 1
- 239000003549 soybean oil Substances 0.000 description 1
- JIWBIWFOSCKQMA-UHFFFAOYSA-N stearidonic acid Natural products CCC=CCC=CCC=CCC=CCCCCC(O)=O JIWBIWFOSCKQMA-UHFFFAOYSA-N 0.000 description 1
- 230000000475 sunscreen effect Effects 0.000 description 1
- 239000000516 sunscreening agent Substances 0.000 description 1
- 239000002344 surface layer Substances 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 229940095064 tartrate Drugs 0.000 description 1
- 229930003799 tocopherol Natural products 0.000 description 1
- 235000010384 tocopherol Nutrition 0.000 description 1
- 229960001295 tocopherol Drugs 0.000 description 1
- 239000011732 tocopherol Substances 0.000 description 1
- 230000001256 tonic effect Effects 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 125000002469 tricosyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 125000002889 tridecyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- PHYFQTYBJUILEZ-IUPFWZBJSA-N triolein Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OCC(OC(=O)CCCCCCC\C=C/CCCCCCCC)COC(=O)CCCCCCC\C=C/CCCCCCCC PHYFQTYBJUILEZ-IUPFWZBJSA-N 0.000 description 1
- 235000019583 umami taste Nutrition 0.000 description 1
- 125000002948 undecyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 235000015112 vegetable and seed oil Nutrition 0.000 description 1
- 239000008158 vegetable oil Substances 0.000 description 1
- 235000015041 whisky Nutrition 0.000 description 1
- GVJHHUAWPYXKBD-IEOSBIPESA-N α-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 description 1
Images
Landscapes
- Cosmetics (AREA)
- Edible Oils And Fats (AREA)
- Medicinal Preparation (AREA)
Description
本発明は、アルコール含有エマルションとその製造方法、特にアルコールを溶媒とした脂肪酸エステルのO/W(油水)型エマルションに関するものである。 The present invention relates to an alcohol-containing emulsion and a method for producing the same, particularly an O / W (oil-water) type emulsion of a fatty acid ester using an alcohol as a solvent.
一般に、油水エマルション(以下、「O/W型エマルション」という。)を取り扱う技術分野では、1価アルコール、ケトン類等の両親媒性有機溶剤をエマルションに多量に混入した場合、液滴が合体して油相と水相が明確な2層に分離(以下、乳化を壊す意で「乳解」という。)することが知られている。両親媒性有機溶剤は油相と水相の両相に相互溶解するため、明確な油水界面を維持できなくなる。すなわち、添加された乳化剤、特に界面活性剤の界面配向が阻止され、液滴の存在を維持できなくなる。 Generally, in the technical field dealing with oil-water emulsions (hereinafter referred to as "O / W type emulsions"), when a large amount of positivable organic solvents such as monovalent alcohols and ketones are mixed in the emulsion, the droplets are united. It is known that the oil phase and the aqueous phase are separated into two distinct layers (hereinafter referred to as "emulsification" to destroy emulsification). Since the amphipathic organic solvent is mutually soluble in both the oil phase and the aqueous phase, it becomes impossible to maintain a clear oil-water interface. That is, the interfacial orientation of the added emulsifier, especially the surfactant, is blocked and the presence of the droplets cannot be maintained.
相互溶解する結果、物質移動により自由で大きな溶解析出が発生して乳解が促進される。これら一連の現象は一般的に起こり得るものである。従って、O/W型エマルションを安定的に保持しようとする場合には、両親媒性有機溶剤を添加しないか、あるいはその添加量を少量にとどめてその影響の低減を図るのが当業者の常識である。逆に、安定なO/W型エマルションを早急に乳解させたい場合には、適量の両親媒性有機溶剤を添加させる手法がよく使われる(特許文献1、非特許文献1,2及び3参照。)。
As a result of mutual dissolution, mass transfer causes free and large dissolution and precipitation, which promotes milking. These series of phenomena are generally possible. Therefore, when trying to stably hold an O / W type emulsion, it is common knowledge of those skilled in the art to not add an amphipathic organic solvent or to reduce the amount of the addition to a small amount. Is. On the contrary, when it is desired to quickly emulsify a stable O / W type emulsion, a method of adding an appropriate amount of amphipathic organic solvent is often used (see Patent Document 1, Non-Patent
ここで、アルコールはエマルションを簡単に破壊して油相と水相の2層に分解してしまう性質を持っているが、エマルションの破壊が防止できればアルコールを溶媒とした機能性物質を含有する食品、医薬組成物、化粧品などへの広範囲な応用が期待できる。 Here, alcohol has the property of easily destroying the emulsion and decomposing it into two layers, an oil phase and an aqueous phase. However, if the emulsion can be prevented from being destroyed, a food containing a functional substance containing alcohol as a solvent. , Pharmaceutical composition, cosmetics, etc. can be expected to be widely applied.
従来例えば、エタノールや食塩が配合されたエマルションとして、HLBが9〜19である化合物及び多価アルコールを添加することにより、平均粒子径が0.1〜0.6μmに収まり、50〜60℃の高温でも安定性に優れ、濁りの持続性の高い入浴剤が得られることが報告されている(特許文献2参照。)。 Conventionally, for example, by adding a compound having an HLB of 9 to 19 and a polyhydric alcohol as an emulsion containing ethanol or salt, the average particle size is kept within 0.1 to 0.6 μm and the temperature is 50 to 60 ° C. It has been reported that a bath agent having excellent stability even at high temperatures and having high turbidity persistence can be obtained (see Patent Document 2).
特許文献3には、油性成分及び非イオン界面活性剤を含有する油相と油相用多価アルコールとからなる系を混合して、その油相用多価アルコールを連続相とするエマルションを形成させた後、当該エマルションに水相用多価アルコール及び/又は低級アルコールを含有する水相を添加して連続相がその油相用多価アルコールを含む水相になるように転相させることにより、高エネルギーの機械的剪断力を用いなくとも、粒子径が極めて微細なO/W型エマルションが得られるエマルションの製造方法が開示されている。
In
特許文献4には、水及び油に対して不溶性もしくは溶解性の低い機能性物質を高濃度に油中あるいは水中に分散させ長期保存可能な機能性エマルションを得ることを目的とし、エタノールにポリグリセリンオレイン酸エステルを添加し、これと植物油とをホモジナイザー、膜乳化、マイクロチャネル乳化などの乳化法を用いて撹拌し、ポリフェノールが高濃度に溶解したエタノール滴が植物油中に分散したE/O型エマルション、あるいはE/O/W型エマルションの製造方法が開示されている。 Patent Document 4 aims to obtain a functional emulsion that can be stored for a long period of time by dispersing a functional substance that is insoluble or low in solubility in water and oil at a high concentration in oil or water, and polyglycerin in ethanol. An E / O type emulsion is added by adding an oleic acid ester, and the vegetable oil is stirred using an emulsification method such as homogenizer, membrane emulsification, or microchannel emulsification. , Or a method for producing an E / O / W type emulsion is disclosed.
特許文献1には、1価アルコール又はそれを溶媒とする溶液(40.0〜80.0vol%以上)と乳化剤(0.1〜50.0vol%)とを含有するエマルションであって、乳化剤として、ポリオキシエチレン硬化ヒマシ油系乳化剤及びポリオキシエチレンヒマシ油系乳化剤の少なくとも1種を含み、エマルションの平均滴径が550nm以上であるアルコール耐性が安定したアルコール含有エマルションが提案されている。 Patent Document 1 describes an emulsion containing a monovalent alcohol or a solution containing the same as a solvent (40.0 to 80.0 vol% or more) and an emulsifier (0.1 to 50.0 vol%) as an emulsifier. , An alcohol-containing emulsion containing at least one of a polyoxyethylene hydrogenated castor oil-based emulsifier and a polyoxyethylene castor oil-based emulsifier and having an average droplet diameter of 550 nm or more and stable alcohol resistance has been proposed.
特許文献5には、トリグリセリン脂肪酸エステルに、その3つの脂肪酸残基の内の2つを加水分解するリパーゼを作用させて脂肪酸を得て、水と、前記脂肪酸と、アルコールと、塩基性アミノ酸とを、脂肪酸/水の質量組成比が1以下かつ脂肪酸/アルコールの質量組成比が1未満となるように混合し、系のpHを6〜8の範囲に調整することで、界面活性剤や乳化剤を用いることなく、食品として許容される材料の組み合わせによって、透明なW/O型エマルションが得られる製造方法が開示されている。
In
上述したように、高濃度のアルコール含有エマルションについてはいくつかの事例が存在する。 As mentioned above, there are some examples of high-concentration alcohol-containing emulsions.
しかしながら、従来報告されているアルコール含有のエマルションは、界面活性剤、乳化剤及び/又は酵素剤などを使用することが必須とされている。その原因は、繰り返すが、そもそもアルコール自体にエマルションの生成を阻害(破壊)する作用があるため、アルコール単体又はアルコールを溶媒とする機能性物質のみによるO/W型エマルションの生成は不可能であったからである。 However, it is essential to use a surfactant, an emulsifier and / or an enzyme agent in the alcohol-containing emulsions conventionally reported. The cause is repeated, but since alcohol itself has an action of inhibiting (destroying) the formation of an emulsion, it is impossible to form an O / W type emulsion using only alcohol or a functional substance using alcohol as a solvent. This is because the.
したがって、これら界面活性剤、乳化剤及び/又は酵素剤を添加することにより、機能性物質が有する本来の物性、すなわち、機序・作用が劣悪に変化し、これを応用した食品、医薬組成物、又は化粧品の品質及び安定性に悪影響を及ぼすことが危惧される。一方、エマルションを生成するために高エネルギーを要する機械的剪断力を用いた従来技術においては、製造コストが嵩むという課題もある。 Therefore, by adding these surfactants, emulsifiers and / or enzyme agents, the original physical characteristics of the functional substance, that is, the mechanism / action is deteriorated, and the foods and pharmaceutical compositions to which the functional substances are applied are used. Or, there is a concern that the quality and stability of cosmetics may be adversely affected. On the other hand, in the conventional technique using a mechanical shearing force that requires high energy to form an emulsion, there is also a problem that the manufacturing cost increases.
つまり、界面活性剤、乳化剤及び/又は酵素剤などを使用することなくアルコール含有エマルションを製造することができれば、経済的に且つ組成物が有する本来の物性を正常に維持することも可能であるが、こうした実用的なアルコール含有エマルションは未だ開発されるに至っていないのが現状である。 That is, if an alcohol-containing emulsion can be produced without using a surfactant, an emulsifier and / or an enzyme agent, it is economically possible to maintain the original physical characteristics of the composition normally. At present, such a practical alcohol-containing emulsion has not yet been developed.
例えば、焼酎の製造中に、焼酎に含まれる脂肪酸エステル等の油性成分は表層に浮上し、空気に触れることで酸化が進み、焼酎の油臭及び濁り発生の原因物質となる。したがって、現在、一般的にはこれを濾過して除去している。一方、脂肪酸エステルの成分は焼酎に旨味やとろみ、芳香を醸し出し、焼酎の風味を向上させる重要な物質でもある。 For example, during the production of shochu, oily components such as fatty acid esters contained in shochu float on the surface layer, and when they come into contact with air, oxidation progresses, which becomes a causative substance of oily odor and turbidity of shochu. Therefore, it is now generally filtered and removed. On the other hand, the fatty acid ester component is also an important substance that brings out the umami, thickening, and aroma of the shochu and improves the flavor of the shochu.
焼酎に含まれる脂肪酸エステルの酸化を防ぐためには、アルコール中に均一に分散させることが肝要である。そこで、発明者らは、悪臭となる油臭を発生させることなく風味高い焼酎を得ることを目的の一つとし、鋭意研究の結果、本発明をするに至った。 In order to prevent the oxidation of fatty acid esters contained in shochu, it is important to disperse them uniformly in alcohol. Therefore, the inventors have made the present invention as a result of diligent research, with one of the purposes being to obtain a high-flavored shochu without generating a bad oily odor.
本発明は上記従来技術の課題に鑑み、食品、医薬組成物、化粧品の分野において、アルコールを含有したエマルションを製造する際、界面活性剤、乳化剤及び/又は酵素剤などを使用することなく、経済的且つ組成物が持つ有用な物性を正常に維持することができるO/W型エマルション及びその製造方法を提供することを目的とする。 In view of the above-mentioned problems of the prior art, the present invention is economical in the fields of foods, pharmaceutical compositions and cosmetics without using surfactants, emulsifiers and / or enzyme agents when producing emulsions containing alcohol. It is an object of the present invention to provide an O / W type emulsion and a method for producing the same, which can normally maintain the useful physical properties of the composition.
このため、本発明の請求項1に係るO/W型エマルションは、1価又は多価のアルコール脂肪酸エステルを油相(O)とし、pHを7.0〜13.0に調整したアルコール又はアルコールを含む溶液を水相(W)とすることを特徴とする。
Therefore, in the O / W type emulsion according to claim 1 of the present invention, the monovalent or polyhydric alcohol fatty acid ester is used as the oil phase (O), and the pH is 7 . It is characterized in that an alcohol adjusted to 0 to 13.0 or a solution containing alcohol is used as an aqueous phase (W).
請求項2に係るO/W型エマルションは、アルコール溶液のアルコール含有量が0.1%以上であり、当該アルコールは炭素数5以下のアルコールであるエタノール、メタノール、1−プロパノール、2−プロパノール、1−ブタノール、2−ブタノール及びイソブタノールから選択された少なくとも1種であることを特徴とする。
In the O / W type emulsion according to
請求項3に係るO/W型エマルションは、水相(W)のpH調整剤が、水酸化ナトリウム、水酸化カリウム、水酸化カルシウム、水酸化マグネシウム、炭酸ナトリウム、炭酸カリウム、炭酸アンモニウム、エリソルビン酸、エリソルビン酸ナトリウム、L−アスコルビン酸、L−アスコルビン酸ナトリウム、アンモニア、リン酸、リン酸ナトリウム、リン酸カリウム、クエン酸、クエン酸ナトリウム、酒石酸、乳酸、乳酸ナトリウム、グリコール酸、塩酸、硝酸、コハク酸、酢酸、酢酸ナトリウム、フマル酸、硫酸、アジピン酸、グルコノデルタラクトン、グルコン酸、グルコン酸カリウム、グルコン酸ナトリウム、コハク酸、コハク酸ナトリウム、ピロリン酸及びリンゴ酸のいずれかであることを特徴とする。
In the O / W type emulsion according to
請求項4に係るO/W型エマルションは、油相に、脂肪酸、脂溶性ビタミンE及び脂溶性ポリフェノール群から選択された少なくとも1種の脂溶性物質を含むことを特徴とする。 The O / W type emulsion according to claim 4 is characterized in that the oil phase contains at least one fat-soluble substance selected from the fatty acid, fat-soluble vitamin E and fat-soluble polyphenol group .
請求項5に係るO/W型エマルションは、水相に、水溶性ビタミンC及び水溶性ポリフェノール群から選択された少なくとも1種の水溶性物質含むことを特徴とする。
The O / W type emulsion according to
請求項6に係る食品は、請求項1乃至請求項5のいずれかに記載のO/W型エマルションを含有することを特徴とする。 The food product according to claim 6 is characterized by containing the O / W type emulsion according to any one of claims 1 to 5.
請求項7に係る医薬品は、請求項1乃至請求項5のいずれかに記載のO/W型エマルションを含有することを特徴とする。 Pharmaceutical according to claim 7, characterized by containing O / W emulsion according to any one of claims 1 to 5.
請求項8に係る化粧品は、請求項1乃至請求項5のいずれかに記載のO/W型エマルションを含有することを特徴とする。 Cosmetics according to claim 8, characterized that you containing O / W emulsion according to any one of claims 1 to 5.
請求項9は、請求項1乃至請求項5のいずれかに記載のO/W型エマルションの製造方法であって、ホモジナイザー又はボルテックスミキサー又は高速回転攪拌分散機又はコロイドミル又は加圧ノズル乳化機(均質機)又は機械的振動攪拌機又は静電場を利用した攪拌機又はシラス多孔質ガラス膜(SPG膜)を用いることを特徴とする。
9. is the method for producing an O / W emulsion according to any one of claims 1 to 5, wherein a homogenizer or a vortex mixer or a high-speed rotary stirring disperser or a colloid mill or a pressure nozzle emulsifier ( It is characterized by using a homogenizer), a mechanical vibration stirrer, a stirrer using an electrostatic field, or a colloidal porous glass film (SPG film).
本発明において、界面活性剤や乳化剤及び/又は酵素剤を使用することなく、pH4.0〜13.0である脂肪酸エステルを含む0.1vol%以上のアルコール溶液を又はこれを溶媒とする溶液に、脂肪酸エステルを含有するO/W型エマルションが得られた。 In the present invention, a 0.1 vol% or more alcohol solution containing a fatty acid ester having a pH of 4.0 to 13.0 or a solution using the same as a solvent is used without using a surfactant, an emulsifier and / or an enzyme agent. , An O / W type emulsion containing a fatty acid ester was obtained.
アルコール分子炭素原子数の多寡にしたがって、炭素原子数の小さいもの(通常、炭素原子数5以下)を低級アルコール、大きいものを高級アルコールと呼ぶ。また、水酸基が1個、2個、3個のアルコールはそれぞれ1価アルコール、2価アルコール(グリコール)、3価アルコールと称し、2価以上のものを多価アルコールと称する。 Alcohol molecules According to the number of carbon atoms, those with a small number of carbon atoms (usually 5 or less carbon atoms) are called lower alcohols, and those with a large number of carbon atoms are called higher alcohols. Alcohols having one, two, or three hydroxyl groups are referred to as monohydric alcohols, divalent alcohols (glycols), and trihydric alcohols, respectively, and alcohols having two or more hydroxyl groups are referred to as polyhydric alcohols.
本発明は、1価アルコール又はそれを溶媒とする溶液を含有するO/W型エマルションであって、1価アルコール又はそれを溶媒とする溶液含有量がエマルション中0.1vol%以上である。 The present invention is an O / W type emulsion containing a monohydric alcohol or a solution using the monohydric alcohol as a solvent, and the content of the monohydric alcohol or the solution using the monohydric alcohol as a solvent is 0.1 vol% or more in the emulsion.
アルコール溶液は1価アルコール又はそれを溶媒とする溶液のpHは4.0〜13.0であり、このpH範囲以外の時に、範囲内になるようにpHの調整を行う。pH調整剤はエマルションの用途、使用目的等に応じて適宜選択することができる。 The pH of the alcohol solution is monohydric alcohol or a solution using the same as a solvent, and the pH is 4.0 to 13.0, and the pH is adjusted so as to be within this pH range when it is outside this pH range. The pH adjuster can be appropriately selected depending on the intended use, purpose of use and the like of the emulsion.
本発明で使用可能なpH調整剤としては、水酸化ナトリウム、水酸化カリウム、水酸化カルシウム、水酸化マグネシウム、炭酸ナトリウム、炭酸カリウム、炭酸アンモニウム、エリソルビン酸、エリソルビン酸ナトリウム、L−アスコルビン酸、L−アスコルビン酸ナトリウム、アンモニア、リン酸、リン酸ナトリウム、リン酸カリウム、クエン酸、クエン酸ナトリウム、酒石酸、乳酸、乳酸ナトリウム、グリコール酸、塩酸、硝酸、コハク酸、酢酸、酢酸ナトリウム、フマル酸、硫酸、アジピン酸、グルコノデルタラクトン、グルコン酸、グルコン酸カリウム、グルコン酸ナトリウム、コハク酸、コハク酸ナトリウム、ピロリン酸、リンゴ酸等が挙げられ、その他pH調整効果のあるものであればどのようなpH調整剤でもよく、特に制限はない。 Examples of the pH adjuster that can be used in the present invention include sodium hydroxide, potassium hydroxide, calcium hydroxide, magnesium hydroxide, sodium carbonate, potassium carbonate, ammonium carbonate, erythorbic acid, sodium erythorbic acid, L-ascorbic acid, and L. -Sodium ascorbate, ammonia, phosphoric acid, sodium phosphate, potassium phosphate, citric acid, sodium citrate, tartaric acid, lactic acid, sodium lactate, glycolic acid, hydrochloric acid, nitrate, succinic acid, acetic acid, sodium acetate, fumaric acid, Sulfuric acid, adipic acid, gluconodeltalactone, gluconic acid, potassium gluconate, sodium gluconate, succinic acid, sodium succinate, pyrophosphate, malic acid, etc. A suitable pH adjuster may be used, and there is no particular limitation.
本発明のpH調整剤は、本発明の効果に影響がない限り、他の成分を含有してもよい。他の成分としては、例えば、各種タンパク質、糖質、脂質、微量元素、ビタミン類等が挙げられる。 The pH adjuster of the present invention may contain other components as long as the effects of the present invention are not affected. Examples of other components include various proteins, sugars, lipids, trace elements, vitamins and the like.
本発明のpH調整剤の形態に特に限定はなく、例えば、固形状、液状、半液体状、顆粒状、粒状、粉末状、カプセル状、クリーム状、ペースト状が挙げられる。本発明のpH調整剤は、上記の各形態に応じて公知の種々の方法にて調製すればよい。 The form of the pH adjuster of the present invention is not particularly limited, and examples thereof include solid, liquid, semi-liquid, granular, granular, powder, capsule, cream, and paste. The pH adjuster of the present invention may be prepared by various known methods according to each of the above-mentioned forms.
尚、別途pH調整剤を添加することなく、pH4.0〜13.0の範囲となるように条件設定することもできる。 It is also possible to set the conditions so that the pH is in the range of 4.0 to 13.0 without adding a separate pH adjuster.
アルコール溶液は1価アルコール又はそれを溶媒とするpH4.0〜13.0の溶液とし、好ましくはpH6.0〜12.0、より好ましくはpH8.0〜12.0である。この範囲内に設定することにより、良好なエマルションを維持することができる。 The alcohol solution is a monohydric alcohol or a solution having a pH of 4.0 to 13.0 using the same as a solvent, preferably pH 6.0 to 12.0, and more preferably pH 8.0 to 12.0. By setting within this range, a good emulsion can be maintained.
本発明のエマルションに含まれる1価アルコールは限定的ではなく、エマルションの用途、使用目的等に応じて適宜選択することができる。特に、本発明では、油相と水相の両方に相互溶解する性質が強いアルコール(両親媒性のアルコール)を好適に用いることができる。 The monohydric alcohol contained in the emulsion of the present invention is not limited, and can be appropriately selected depending on the intended use, purpose of use, etc. of the emulsion. In particular, in the present invention, an alcohol having a strong property of being mutually soluble in both an oil phase and an aqueous phase (amphipathic alcohol) can be preferably used.
本発明で使用するアルコールは、炭素数5以下のアルコールが好ましい。例えば、エタノール、メタノール、1−プロパノール、2−プロパノール、1−ブタノール、2−ブタノール、イソブタノール等が挙げられる。 The alcohol used in the present invention is preferably an alcohol having 5 or less carbon atoms. For example, ethanol, methanol, 1-propanol, 2-propanol, 1-butanol, 2-butanol, isobutanol and the like can be mentioned.
本発明で使用するアルコールは、1−ブタノール又はエタノールのいずれかがより好ましく、エタノールが最も好ましい。 As the alcohol used in the present invention, either 1-butanol or ethanol is more preferable, and ethanol is most preferable.
1価アルコール又は前記アルコール溶液のアルコール含有量は0.1vol%以上とし、好ましくは15.0〜80.0vol%、より好ましくは20.0〜50.0vol%である。この範囲内に設定することにより、良好なエマルションを維持することができる。 The alcohol content of the monohydric alcohol or the alcohol solution is 0.1 vol% or more, preferably 15.0 to 80.0 vol%, and more preferably 20.0 to 50.0 vol%. By setting within this range, a good emulsion can be maintained.
ここで、脂肪酸とは、長鎖炭化水素の1価のカルボン酸である。一般的に、炭素数2〜4個のものを短鎖脂肪酸(低級脂肪酸)、5〜12個のものを中鎖脂肪酸、12個以上のものを長鎖脂肪酸(高級脂肪酸)と称し、大きくは不飽和脂肪酸と飽和脂肪酸に区分される。不飽和脂肪酸には、体内で作れない多価不飽和脂肪酸と、体内で作ることのできる一価不飽和脂肪酸がある。 Here, the fatty acid is a monovalent carboxylic acid of a long-chain hydrocarbon. Generally, those having 2 to 4 carbon atoms are referred to as short-chain fatty acids (lower fatty acids), those having 5 to 12 carbon atoms are referred to as medium-chain fatty acids, and those having 12 or more carbon atoms are referred to as long-chain fatty acids (higher fatty acids). It is divided into unsaturated fatty acids and saturated fatty acids. Unsaturated fatty acids include polyunsaturated fatty acids that cannot be made in the body and monounsaturated fatty acids that can be made in the body.
脂肪酸エステルは、脂肪酸のカルボキシル基がアルコールとエステル結合した化合物である。アルコールの価数によって1価アルコール脂肪酸エステル、2価アルコール脂肪酸エステル、3価アルコール脂肪酸エステルなどと呼ばれる。 A fatty acid ester is a compound in which the carboxyl group of a fatty acid is ester-bonded to an alcohol. Depending on the valence of the alcohol, it is called a monohydric alcohol fatty acid ester, a dihydric alcohol fatty acid ester, a trihydric alcohol fatty acid ester, or the like.
本発明において1価アルコール又は前記アルコール溶液に含まれる脂肪酸エステルは特に限定されるものではなく、エマルションの用途、使用目的等に応じて適宜選択することができる。 In the present invention, the monohydric alcohol or the fatty acid ester contained in the alcohol solution is not particularly limited, and can be appropriately selected depending on the intended use, purpose of use and the like of the emulsion.
本発明で使用する1価又は多価のアルコール脂肪酸エステルは、飽和脂肪酸エステル又は不飽和脂肪酸エステルのいずれかを限定しない。例えば、飽和脂肪酸エステルとしては、蟻酸エステル、酢酸エステル、プロピオン酸エステル、酪酸エステル、吉草酸エステル、カプロン酸エステル、エナント酸エステル、カプリル酸エステル、ペラルゴン酸エステル、カプリン酸エステル、ウンデシル酸エステル、ラウリン酸エステル、トリデシル酸エステル、ミリスチン酸エステル、ペンタデシル酸エステル、パルミチン酸エステル、マルガリン酸エステル、ステアリン酸エステル、ノナデシル酸エステル、アラキジン酸エステル、ヘンイコシル酸エステル、ベヘン酸エステル、トリコシル酸エステル、リグノセリン酸エステル等が挙げられる。 The monovalent or polyvalent alcohol fatty acid ester used in the present invention is not limited to either a saturated fatty acid ester or an unsaturated fatty acid ester. For example, saturated fatty acid esters include formic acid ester, acetic acid ester, propionic acid ester, butyric acid ester, valeric acid ester, caproic acid ester, enanthate acid ester, capric acid ester, pelargonic acid ester, capric acid ester, undecyl acid ester, and laurin. Acid ester, Tridecyl acid ester, Myristic acid ester, Pentadecyl acid ester, Palmitic acid ester, Margaric acid ester, Steaic acid ester, Nonadesil acid ester, Arakidic acid ester, Henikosyl acid ester, Bechenic acid ester, Tricosyl acid ester, Lignoceric acid ester And so on.
1価又は多価のアルコール不飽和脂肪酸エステルとしては、ω−3脂肪酸:α−リノレン酸エステル、ステアリドン酸エステル、エイコサペンタエン酸エステル、ドコサペンタエン酸エステル、ドコサヘキサエン酸エステル、ω−6脂肪酸:リノール酸エステル、γ−リノレン酸エステル、ジホモ−γ−リノレン酸エステル、アラキドン酸エステル、ドコサペンタエン酸エステル、ω−7脂肪酸:パルミトレイン酸エステル、バクセン酸エステル、パウリン酸エステル、ω−9脂肪酸:オレイン酸エステル、エライジン酸エステル、エルカ酸エステル、ネルボン酸エステル、ω−10脂肪酸:サピエン酸エステル等が挙げられる。 Examples of the monovalent or polyvalent alcohol unsaturated fatty acid ester include ω-3 fatty acid: α-linolenic acid ester, stearidonic acid ester, eikosapentaenoic acid ester, docosapentaenoic acid ester, docosahexaenoic acid ester, and ω-6 fatty acid: linole. Acid ester, γ-linolenic acid ester, dihomo-γ-linolenic acid ester, arachidonic acid ester, docosapentaenoic acid ester, ω-7 fatty acid: palmitoleic acid ester, bacsenic acid ester, pauronic acid ester, ω-9 fatty acid: olein Acid esters, ellagic acid esters, erucic acid esters, nervonic acid esters, ω-10 fatty acids: sapienoic acid esters and the like can be mentioned.
本発明で使用する1価又は多価のアルコール脂肪酸エステルは少なくとも1種類以上の脂肪酸エステルを含む。 The monovalent or polyhydric alcohol fatty acid ester used in the present invention contains at least one fatty acid ester.
本発明で使用する1価又は多価のアルコール脂肪酸エステルは、本発明の効果に影響がない限り、他の成分を含有してもよい。他の成分としては、例えば、各種タンパク質、糖質、脂質、微量元素、ビタミンC、ビタミンE類等が挙げられる。 The monovalent or polyhydric alcohol fatty acid ester used in the present invention may contain other components as long as the effects of the present invention are not affected. Examples of other components include various proteins, sugars, lipids, trace elements, vitamin C, vitamin E and the like.
本発明で使用する1価又は多価のアルコール脂肪酸エステルの形態に特に制限はなく、例えば、固形状、液状、半液体状、顆粒状、粒状、粉末状、カプセル状、クリーム状、ペースト状が挙げられる。 The form of the monovalent or polyhydric alcohol fatty acid ester used in the present invention is not particularly limited, and may be, for example, solid, liquid, semi-liquid, granular, granular, powdery, capsule-like, cream-like, or paste-like. Can be mentioned.
本発明によれば、以下の優れた効果が得られる。
(1)食品、医薬組成物、化粧品の分野において、アルコールを含有したエマルションを製造する際、界面活性剤、乳化剤及び/又は酵素剤などを使用することなく、経済的且つ組成物が持つ有用な物性を正常に維持することができるアルコール含有エマルションが得られる。
(2)アルコールを含有したエマルション溶液を含有する食品、医薬組成物又は化粧品において、従来の指摘臭気を緩和・改善できる効果が期待できる。
According to the present invention, the following excellent effects can be obtained.
(1) In the fields of foods, pharmaceutical compositions, and cosmetics, when producing an emulsion containing alcohol, it is economical and useful because the composition does not use a surfactant, an emulsifier, and / or an enzyme agent. An alcohol-containing emulsion capable of maintaining normal physical properties can be obtained.
(2) In foods, pharmaceutical compositions or cosmetics containing an emulsion solution containing alcohol, the effect of alleviating or improving the conventionally pointed odor can be expected.
以下に示す各実施例により本発明を説明するが、本発明はこれらの実施例に限定されるものではない。 The present invention will be described with reference to the following examples, but the present invention is not limited to these examples.
実施例1では、表1に示す条件下で、アルコール含有O/W型エマルションを調製した(図1参照。)。これらのエマルションの安定性とpH範囲について検討した。 In Example 1, an alcohol-containing O / W type emulsion was prepared under the conditions shown in Table 1 (see FIG. 1). The stability and pH range of these emulsions were investigated.
表1に示すように、異なるpHのpH調整溶液にアルコール濃度36vol%エタノールをそれぞれ混合した水相を用い、各々O/W型エマルションを調製して乳化状態を観察した。水相には、pH1.0、pH2.0、pH3.0、pH4.0、pH5.0、pH6.0、pH7.0、pH8.0、pH9.0、pH10.0、pH11.0、pH12.0、pH13.0、pH13.5のpH調整溶液各種(水酸化ナトリウム(特級)、塩酸(特級);キシダ化学株式会社製)と36vol%エタノール(エタノール(特級);キシダ化学株式会社製)の混合液をそれぞれ使用した。油相には、脂肪酸エステル混和液(焼酎由来のパルミンチン酸エチル、リノール酸エチル、オレイン酸エチル、ステアリン酸エチル、カプリン酸エチル、ミリスチン酸エチル、ラウリン酸エチル及びα−リノレン酸エチル等の脂肪酸エステル混和液;霧島酒造株式会社製)、サラダ油(日清オイリオグループ株式会社製)、魚油(大塚製薬株式会社輸入の米国製)を使用した。 As shown in Table 1, each O / W type emulsion was prepared using an aqueous phase in which alcohol concentration 36 vol% ethanol was mixed with pH adjustment solutions having different pH, and the emulsified state was observed. The aqueous phase has pH 1.0, pH 2.0, pH 3.0, pH 4.0, pH 5.0, pH 6.0, pH 7.0, pH 8.0, pH 9.0, pH 10.0, pH 11.0, pH 12 .0, pH 13.0, pH 13.5 pH adjustment solutions (sodium hydroxide (special grade), hydrochloric acid (special grade); manufactured by Kishida Chemical Co., Ltd.) and 36 vol% ethanol (ethanol (special grade); manufactured by Kishida Chemical Co., Ltd.) The mixed solution of each was used. In the oil phase, fatty acid esters such as fatty acid ester mixture (ethyl palminate derived from shochu, ethyl linoleate, ethyl oleate, ethyl stearate, ethyl caprate, ethyl myristate, ethyl laurate and ethyl α-linolenate) Admixture; Kirishima Sake Brewery Co., Ltd.), salad oil (Nisshin Oillio Group Co., Ltd.), and fish oil (Otsuka Pharmaceutical Co., Ltd. imported from the United States) were used.
100mlの水相(各pH調整溶液とエタノールの各混合液)に1.0mlの油相(脂肪酸エステル混和液、サラダ油、魚油)をそれぞれ添加し、ホモミキサーを使って24,000rpmで1分間撹拌乳化してO/W型エマルションを室温25℃にて調製した。O/W型エマルションは調製直後、静置1時間、静置2時間及び静置24時間経過後、目視により乳化状態の定性的な評価を行った。目視評価では、表2に示すように、調製直後と見かけ上ほとんど変化がなかったり、あるいは顕微鏡下で油滴が均一状態であり、油滴径はほぼ変化がなかったエマルションには「◎」、目視で調製直後と見かけ上ほとんど変化がなかったり、あるいは顕微鏡下で油滴が均一状態であったが、油滴径は大きくなったエマルションには「○」、一部乳解が発生したり、あるいは顕微鏡下で明らかに油滴の合一が進んだエマルションには「△」、完全に乳解が起こったエマルションには「×」と記した。油滴粒子の状態観察には光学顕微鏡を用いた。 Add 1.0 ml of oil phase (fatty acid ester mixture, salad oil, fish oil) to 100 ml of aqueous phase (mixture of each pH adjustment solution and ethanol), and stir at 24,000 rpm for 1 minute using a homomixer. It was emulsified to prepare an O / W type emulsion at room temperature of 25 ° C. Immediately after the O / W type emulsion was prepared, the emulsified state was visually evaluated qualitatively after 1 hour of standing, 2 hours of standing and 24 hours of standing. In the visual evaluation, as shown in Table 2, there was almost no change in appearance from immediately after preparation, or the oil droplets were in a uniform state under a microscope, and the oil droplet diameter was almost unchanged. There was almost no change in appearance from immediately after preparation by visual inspection, or the oil droplets were in a uniform state under a microscope, but the emulsion with a larger oil droplet diameter was marked with "○", and some emulsions were generated. Alternatively, an emulsion in which oil droplets are clearly coalesced under a microscope is marked with "Δ", and an emulsion in which completely emulsion has occurred is marked with "x". An optical microscope was used to observe the state of the oil droplets.
表2から分かるように、脂肪酸エステル混和液、サラダ油及び魚油を油相としたエマルションは全て、水相がpH 1.0〜3.0の場合、及びpH13.5の場合は、O/W型エマルションができた後、極めて短時間で乳解され、油相が浮上し、水相が徐々に透明になった。しかし、水相がpH4.0〜13.0の場合は、均一に白く濁った安定したO/W型エマルションが得られた(図2〜4参照。)。目視評価の結果から、乳化水相のpHは4.0〜13.0であることが望ましいことが分かった。さらに、乳化水相のpHは6.0〜13.0がより好ましく、特にpH8.0〜13.0が最も好ましいことが分かった。 As can be seen from Table 2, all emulsions containing fatty acid ester admixtures, salad oil and fish oil as oil phases are O / W type when the aqueous phase is pH 1.0 to 3.0 and when the pH is 13.5. After the emulsion was formed, it was emulsified in a very short time, the oil phase floated, and the aqueous phase gradually became transparent. However, when the aqueous phase had a pH of 4.0 to 13.0, a stable O / W emulsion having a uniform white turbidity was obtained (see FIGS. 2 to 4). From the results of the visual evaluation, it was found that the pH of the emulsified aqueous phase is preferably 4.0 to 13.0. Further, it was found that the pH of the emulsified aqueous phase is more preferably 6.0 to 13.0, and particularly preferably pH 8.0 to 13.0.
したがって、アルコール溶液を水相とした脂肪酸エステルの乳化に際しては、水相がpH4.0〜13.0の場合、脂肪酸エステル混和液、サラダ油、及び魚油全てにおいて、安定した良好なO/W型エマルションが得られた。光学顕微鏡観察によれば、脂肪酸エステル混和液のO/W型エマルションは、サラダ油のO/W型エマルション及び魚油のO/W型エマルションより油滴の粒子径が小さかった(図5参照。)。さらに、レーザ回折式粒度分布測定装置(島津SALD−7100;測定波長は375nm)を用いて、油滴の粒子径を測定したところ、脂肪酸エステル混和液のO/W型エマルションの油滴の粒子径は0.518±0.141μm、サラダ油のO/W型エマルションの油滴の粒子径は2.102±0.361μm、魚油のO/W型エマルションの油滴の粒子径は1.755±0.328μmであった。 Therefore, when emulsifying a fatty acid ester using an alcohol solution as an aqueous phase, when the aqueous phase has a pH of 4.0 to 13.0, a stable and good O / W type emulsion is used in all of the fatty acid ester admixture, salad oil, and fish oil. was gotten. According to the observation with an optical microscope, the O / W type emulsion of the fatty acid ester mixture had a smaller particle size of the oil droplets than the O / W type emulsion of salad oil and the O / W type emulsion of fish oil (see FIG. 5). Furthermore, when the particle size of the oil droplets was measured using a laser diffraction type particle size distribution measuring device (Shimadzu SALD-7100; measurement wavelength is 375 nm), the particle size of the oil droplets of the O / W type emulsion of the fatty acid ester mixture was measured. 0.518 ± 0.141 μm, the particle size of the oil droplets of the O / W type emulsion of salad oil is 2.102 ± 0.361 μm, and the particle size of the oil droplets of the O / W type emulsion of fish oil is 1.755 ± 0. It was .328 μm.
脂肪酸エステル混和液は、1価アルコール脂肪酸エステルである。サラダ油、魚油は3価の多価アルコール脂肪酸エステルである。 The fatty acid ester mixture is a monohydric alcohol fatty acid ester. Salad oil and fish oil are trihydric polyhydric alcohol fatty acid esters.
以上の実験結果から、異なるpH別のアルコール溶液を水相とした脂肪酸エステルの乳化においては、1価アルコール脂肪酸エステルを用いることが最も好ましいことが分かった。 From the above experimental results, it was found that it is most preferable to use a monohydric alcohol fatty acid ester in the emulsification of a fatty acid ester using an alcohol solution having a different pH as an aqueous phase.
実施例2では、表3に示す条件下で、アルコール含有O/W型エマルションを調製し、それらのエマルションの安定性とpH調整緩衝液を用いたpH範囲について検討した。 In Example 2, alcohol-containing O / W emulsions were prepared under the conditions shown in Table 3, and the stability of those emulsions and the pH range using a pH adjustment buffer were examined.
表3に示すように、異なるpHのpH調整緩衝液にアルコール濃度36vol%エタノールをそれぞれ混合した水相を用い、各々O/W型エマルションを調製して、その乳化状態を観察した。水相には、pH1.0(KC1−HC1緩衝液;東京化成工業株式会社製)、pH2.0とpH3.0(リン酸緩衝液;NaH2PO4とNa2HPO4は関東化学株式会社製)、pH4.0とpH5.0(酢酸緩衝液;CH3COOHとCH3COONaは関東化学株式会社製)、pH6.0、pH7.0とpH8.0(リン酸緩衝液;NaH2PO4とNa2HPO4は関東化学株式会社製)、pH9.0とpH10.0(炭酸緩衝液;Na2CO3とNaHCO3は関東化学株式会社製)、pH11.0とpH12.0(リン酸緩衝液;NaH2PO4とNa2HPO4は関東化学株式会社製)、pH13.0(KCl−NaOH緩衝液;東京化成工業株式会社製)、pH13.5(NaOHはキシダ化学株式会社製)のpH調整緩衝液各種と36vol%エタノール(エタノール(特級);キシダ化学株式会社製)の混合液をそれぞれ使用した。油相には、脂肪酸エステル混和液(焼酎由来のパルミンチン酸エチル、リノール酸エチル、オレイン酸エチル、ステアリン酸エチル、カプリン酸エチル、ミリスチン酸エチル、ラウリン酸エチル及びα−リノレン酸エチル等の脂肪酸エステル混和液;霧島酒造株式会社製)を使用した。 As shown in Table 3, O / W type emulsions were prepared by using aqueous phases in which alcohol concentration 36 vol% ethanol was mixed with pH adjustment buffers having different pH, and the emulsified state was observed. For the aqueous phase, pH 1.0 (KC1-HC1 buffer; manufactured by Tokyo Kasei Kogyo Co., Ltd.), pH 2.0 and pH 3.0 (phosphate buffer; NaH 2 PO 4 and Na 2 HPO 4 are Kanto Chemical Co., Ltd.) , PH 4.0 and pH 5.0 (acetate buffer; CH 3 COOH and CH 3 COONa are manufactured by Kanto Chemical Co., Ltd.), pH 6.0, pH 7.0 and pH 8.0 (phosphate buffer; NaH 2 PO) 4 and Na 2 HPO 4 are manufactured by Kanto Chemical Co., Ltd.), pH 9.0 and pH 10.0 (carbonic acid buffer; Na 2 CO 3 and Na HCO 3 are manufactured by Kanto Chemical Co., Ltd.), pH 11.0 and pH 12.0 (phosphorus). Acid buffer; NaH 2 PO 4 and Na 2 HPO 4 are manufactured by Kanto Chemical Co., Ltd.), pH 13.0 (KCl-NaOH buffer; manufactured by Tokyo Kasei Kogyo Co., Ltd.), pH 13.5 (NaOH is manufactured by Kishida Chemical Co., Ltd.) ) And 36 vol% ethanol (ethanol (special grade); manufactured by Kishida Chemical Co., Ltd.) were used. In the oil phase, fatty acid esters such as fatty acid ester mixture (ethyl palminate derived from shochu, ethyl linoleate, ethyl oleate, ethyl stearate, ethyl caprice, ethyl myristate, ethyl laurate and ethyl α-linolenate) Mixture solution; manufactured by Kirishima Sake Brewery Co., Ltd.) was used.
100mlの水相(各pH調整緩衝液と36vol%エタノールの各混合液)に1ml油相(脂肪酸エステル混和液)を添加し、ホモミキサーを使って24,000rpmで1分間撹拌乳化してO/W型エマルションを室温25℃にて調製した。O/W型エマルションは調製直後、静置1時間、静置2時間及び静置24時間経過後に目視による乳化状態の定性的な評価を行った。エマルションの評価方法は、実施例1と同様に目視評価とした。 Add 1 ml oil phase (fatty acid ester mixture) to 100 ml aqueous phase (mixture of each pH adjustment buffer and 36 vol% ethanol), stir and emulsify at 24,000 rpm for 1 minute using a homomixer, and O / A W-type emulsion was prepared at room temperature of 25 ° C. Immediately after preparation, the O / W type emulsion was visually evaluated for qualitative evaluation of the emulsified state after 1 hour of standing, 2 hours of standing, and 24 hours of standing. The evaluation method of the emulsion was a visual evaluation in the same manner as in Example 1.
脂肪酸エステル混和液を油相としたO/W型エマルションにおいて、pH調整緩衝液で調製した水相がpH1.0〜13.5の場合、評価結果は実施例1と同様の結果であった。水相がpH1.0〜3.0の場合、及びpH13.5の場合はO/W型エマルションができた後、極めて短時間で乳解され、油相が浮上し、水相が徐々に透明になった。しかし、水相がpH4.0〜13.0の場合、均一に白く濁った安定したO/W型エマルションを得ることができた (図6参照。)。目視評価の結果から、乳化水相のpHは4.0〜13.0であることが望ましいことが分かった。さらに、乳化水相のpHは6.0〜13.0がより好ましく、特にpH8.0〜13.0が最も好ましいことが分かった。 In the O / W type emulsion using the fatty acid ester admixture as the oil phase, when the aqueous phase prepared by the pH adjustment buffer had a pH of 1.0 to 13.5, the evaluation results were the same as in Example 1. When the aqueous phase is pH 1.0 to 3.0 and when the pH is 13.5, after the O / W type emulsion is formed, it is emulsified in an extremely short time, the oil phase floats, and the aqueous phase gradually becomes transparent. Became. However, when the aqueous phase had a pH of 4.0 to 13.0, a stable O / W emulsion having a uniform white turbidity could be obtained (see FIG. 6). From the results of the visual evaluation, it was found that the pH of the emulsified aqueous phase is preferably 4.0 to 13.0. Further, it was found that the pH of the emulsified aqueous phase is more preferably 6.0 to 13.0, and particularly preferably pH 8.0 to 13.0.
上記実施例1と実施例2の結果から分かるように、脂肪酸エステル混和液を油相としたO/W型エマルションにおいて、乳化水相のpHは4.0〜13.0であることが望ましい。さらに、乳化水相のpHは6.0〜13.0がより好ましく、特にpH8.0〜13.0が最も好ましいことが分かった。 As can be seen from the results of Examples 1 and 2, the pH of the emulsified aqueous phase is preferably 4.0 to 13.0 in the O / W type emulsion using the fatty acid ester admixture as the oil phase. Further, it was found that the pH of the emulsified aqueous phase is more preferably 6.0 to 13.0, and particularly preferably pH 8.0 to 13.0.
実施例3では、表4に示す条件下で、アルコールを含有したO/W型エマルションを調製し、これらのエマルションの安定性とアルコール濃度について検討した。 In Example 3, O / W type emulsions containing alcohol were prepared under the conditions shown in Table 4, and the stability and alcohol concentration of these emulsions were examined.
表4に示すように、pH12.0の100mMリン酸緩衝液(リン酸緩衝液;NaH2PO4とNa2HPO4は関東化学株式会社製)にアルコール濃度の異なるエタノールをそれぞれ混合した水相を用い、各々O/W型エマルションを調製して、その乳化状態を観察した。水相となる溶媒には、特級エタノールを使用した。エタノール濃度が、0.0vol%、5.0vol%、10.0vol%、15.0vol%、20.0vol%、25.0vol%、30.0vol%、35.0vol%、40.0vol%、45.0vol%、50.0vol%、55.0vol%、60.0vol%となるように調整し、それぞれをpH12.0の100mMリン酸緩衝液と混合して水相とした。100mlのpH12.0の100mMリン酸緩衝液とエタノールの混合液に1ml脂肪酸エステル混和液を油相として添加し、ホモミキサーを使って24,000rpmで1分間撹拌乳化してO/W型エマルションを室温25℃にて調製した。O/W型エマルションは調製直後、静置1時間、静置2時間及び静置24時間経過後に、目視により乳化状態の定性的な評価を行った。エマルションの評価方法は、実施例1と同様に目視で行った。 As shown in Table 4, an aqueous phase in which ethanol having different alcohol concentrations is mixed with 100 mM phosphate buffer (phosphate buffer; NaH 2 PO 4 and Na 2 HPO 4 are manufactured by Kanto Chemical Co., Ltd.) at pH 12.0. Each O / W type emulsion was prepared and the emulsified state was observed. Special grade ethanol was used as the solvent for the aqueous phase. Ethanol concentration is 0.0vol%, 5.0vol%, 10.0vol%, 15.0vol%, 20.0vol%, 25.0vol%, 30.0vol%, 35.0vol%, 40.0vol%, 45. The concentrations were adjusted to 0.0 vol%, 50.0 vol%, 55.0 vol%, and 60.0 vol%, and each was mixed with a 100 mM phosphate buffer solution having a pH of 12.0 to prepare an aqueous phase. A 1 ml fatty acid ester mixture is added as an oil phase to a 100 ml pH 12.0 100 mM phosphate buffer and ethanol mixture, and the mixture is stirred and emulsified at 24,000 rpm for 1 minute using a homomixer to form an O / W type emulsion. Prepared at room temperature 25 ° C. Immediately after preparation, the O / W type emulsion was visually evaluated qualitatively in an emulsified state after 1 hour of standing, 2 hours of standing, and 24 hours of standing. The evaluation method of the emulsion was visually performed in the same manner as in Example 1.
pH12.0の100mMリン酸緩衝液と特級エタノール(0.0〜60.0vol%)混合液に、油相の脂肪酸エステル混和液を添加し乳化した。アルコール濃度の異なる全ての組合せにおいて、O/W型エマルションが得られた。目視評価の結果、このO/W型エマルションは水相のアルコール濃度0.0〜60.0vol%で乳化が可能であり、乳化水相のアルコール濃度は10.0〜60.0vol%がより好ましく、特に20.0〜50.0vol%のアルコール濃度が最も好ましいことが分かった。よって、アルコールを含むエマルションとしては、水相のアルコール濃度は0.1vol%以上であることが好適であると言える(図7参照。)。 An oil phase fatty acid ester mixture was added to a mixture of 100 mM phosphate buffer having a pH of 12.0 and special grade ethanol (0.0 to 60.0 vol%) and emulsified. O / W type emulsions were obtained for all combinations with different alcohol concentrations. As a result of visual evaluation, this O / W type emulsion can be emulsified with an alcohol concentration of 0.0 to 60.0 vol% in the aqueous phase, and the alcohol concentration of the emulsified aqueous phase is more preferably 10.0 to 60.0 vol%. In particular, an alcohol concentration of 20.0 to 50.0 vol% was found to be the most preferable. Therefore, as an emulsion containing alcohol, it can be said that the alcohol concentration in the aqueous phase is preferably 0.1 vol% or more (see FIG. 7).
実施例4では、表5に示す条件下で、アルコール飲料の一種である焼酎を水相とするO/W型エマルションを調製した。焼酎のpH調整は行わず、このエマルションの安定性について検討した。 In Example 4, an O / W type emulsion having shochu, which is a kind of alcoholic beverage, as an aqueous phase was prepared under the conditions shown in Table 5. The pH of the shochu was not adjusted, and the stability of this emulsion was investigated.
pH4.1のアルコール濃度36.0vol%焼酎(霧島酒造株式会社製)を水相とした。油相には、脂肪酸エステル混和液を使用した。100mlの焼酎に1mlの脂肪酸エステル混和液を添加し、ホモミキサーを使って24,000rpmで1分間撹拌乳化してO/W型エマルションを室温25℃にて調製した。O/W型エマルションを調製直後、静置1時間、静置2時間及び静置24時間経過後に、目視により乳化状態の定性的な評価を行った。エマルションの評価方法は、実施例1と同様に目視で行った。さらに、レーザ回折式粒度分布測定装置(島津SLAD−7100;測定波長は375nm)を用いて、油滴の粒子径を測定した。 An alcohol concentration of 36.0 vol% shochu (manufactured by Kirishima Shuzo Co., Ltd.) having an alcohol concentration of pH 4.1 was used as the aqueous phase. A fatty acid ester mixture was used as the oil phase. A 1 ml fatty acid ester mixture was added to 100 ml of shochu, and the mixture was stirred and emulsified at 24,000 rpm for 1 minute using a homomixer to prepare an O / W type emulsion at room temperature of 25 ° C. Immediately after the O / W type emulsion was prepared, the emulsified state was visually evaluated qualitatively after 1 hour of standing, 2 hours of standing, and 24 hours of standing. The evaluation method of the emulsion was visually performed in the same manner as in Example 1. Further, the particle size of the oil droplet was measured using a laser diffraction type particle size distribution measuring device (Shimadzu SLAD-7100; measurement wavelength was 375 nm).
pH4.1のアルコール濃度36.0vol%焼酎に油相の脂肪酸エステル混和液を添加して乳化させたところ、安定的なO/W型エマルションが得られた(図8参照。)。油滴の粒子径は1.202±0.112 μmであった。 When the fatty acid ester mixture of the oil phase was added to the alcohol concentration of 36.0 vol% at pH 4.1 and emulsified, a stable O / W type emulsion was obtained (see FIG. 8). The particle size of the oil droplet was 1.202 ± 0.112 μm.
さらに実施例4において、アルコール濃度36.0vol%焼酎と脂肪酸エステル混和液から得られたO/W型エマルション1mlを、100mlのアルコール濃度36.0vol%焼酎に添加し、さらに割り水してアルコール濃度25.0vol%焼酎(B)を調製した。このアルコール濃度25.0vol%焼酎(B)を、20代〜60代の成人女性3人及び成人男性7人、計10人のパネラーに試飲してもらい、焼酎の香り、呈味の官能評価を行った。比較用のコントロール焼酎(A)としては、pH4.1のアルコール濃度36.0vol%焼酎100mlと脂肪酸エステル混和液1mlを、ホモミキサーにより1,000rpmで1分間、室温25℃にて撹拌して得られたO/W型エマルション(油滴の粒子径;1.313±0.641μm)1mlを100mlアルコール濃度36.0vol%焼酎に添加し、さらに割り水してアルコール濃度25.0vol%焼酎を調製した。官能評価の結果を表8に示す。焼酎(B)は、コントロール焼酎(A)と比較して焼酎の油臭がやや低減し、とろみが増して、まろやかになったと評価された。 Further, in Example 4, 1 ml of an O / W type emulsion obtained from an alcohol concentration of 36.0 vol% shochu and a fatty acid ester mixed solution was added to 100 ml of alcohol concentration of 36.0 vol% shochu, and further divided into water to have an alcohol concentration. 25.0 vol% alcohol (B) was prepared. This alcohol concentration of 25.0 vol% shochu (B) was tasted by a total of 10 panelists, 3 adult females in their 20s and 60s and 7 adult males, to evaluate the aroma and taste of the shochu. went. As the control shochu (A) for comparison, 100 ml of alcohol concentration 36.0 vol% shochu with a pH of 4.1 and 1 ml of a fatty acid ester mixture were stirred at 1,000 rpm for 1 minute at room temperature 25 ° C. with a homomixer. 1 ml of the obtained O / W type emulsion (grain size of oil droplets; 1.313 ± 0.641 μm) was added to 100 ml alcohol concentration 36.0 vol% shochu, and further divided into water to prepare alcohol concentration 25.0 vol% shochu. bottom. The results of the sensory evaluation are shown in Table 8. It was evaluated that the shochu (B) had a slightly reduced oily odor, an increased thickening, and a mellowness as compared with the control shochu (A).
実施例5では、表6に示す条件下で、アルコール飲料の一種である焼酎及びpH11.0調整溶液の混合液を水相とするエマルションを調製した。このエマルションの安定性について検討した。 In Example 5, under the conditions shown in Table 6, an emulsion having a mixed solution of shochu, which is a kind of alcoholic beverage, and a pH 11.0 adjusted solution as an aqueous phase was prepared. The stability of this emulsion was investigated.
アルコール濃度36.0vol%焼酎とpH11.0調整溶液の混合液を水相とした。油相には、脂肪酸エステル混和液を使用した。100mlの水相に脂肪酸エステル混和液を1ml添加して、ホモミキサーを使って24,000rpmで1分間撹拌乳化を行い、O/W型エマルションを室温25℃にて調製した。O/W型エマルションは調製直後、静置1時間、静置2時間及び静置24時間経過後に、目視による乳化状態の定性的な評価を行った。エマルション評価方法は、実施例1と同様に目視により行い、実施例4と同様に油滴の粒子径を測定して行った。 A mixed solution of alcohol concentration 36.0 vol% shochu and a pH 11.0 adjusted solution was used as an aqueous phase. A fatty acid ester mixture was used as the oil phase. 1 ml of the fatty acid ester mixture was added to 100 ml of the aqueous phase, and the mixture was stirred and emulsified at 24,000 rpm for 1 minute using a homomixer to prepare an O / W type emulsion at room temperature of 25 ° C. Immediately after preparation, the O / W type emulsion was visually evaluated for qualitative evaluation of the emulsified state after 1 hour of standing, 2 hours of standing, and 24 hours of standing. The emulsion evaluation method was carried out visually in the same manner as in Example 1, and the particle size of the oil droplet was measured in the same manner as in Example 4.
アルコール濃度36.0vol%焼酎とpH11.0調整溶液の混合液に脂肪酸エステル混和液を添加して乳化させたところ、安定的なO/W型エマルションが得られた(図9参照。)。油滴の粒子径は0.845±0.072μmであった。 When a fatty acid ester mixed solution was added to a mixed solution of alcohol concentration 36.0 vol% shochu and a pH 11.0 adjusted solution and emulsified, a stable O / W type emulsion was obtained (see FIG. 9). The particle size of the oil droplet was 0.845 ± 0.072 μm.
実施例4と実施例5の目視評価及び油滴の粒子径の測定結果より、調製したO/W型エマルションを比較すると、実施例5の方が油滴の粒子径が小さくなり、安定したO/W型エマルションを示した。これは、実施例5で使用したpH調整溶液のpH11.0が、実施例1及び実施例2に基づくアルコール含有O/W型エマルションに最適な乳化水相のpH8.0〜13.0の範囲内であったためと考察される。 Comparing the prepared O / W type emulsions from the visual evaluations of Examples 4 and 5 and the measurement results of the particle size of the oil droplets, the particle size of the oil droplets was smaller in Example 5 and stable O. / W type emulsion is shown. This is because the pH of the pH adjustment solution used in Example 5 is 11.0, and the pH of the emulsified aqueous phase suitable for the alcohol-containing O / W type emulsion based on Examples 1 and 2 is in the range of 8.0 to 13.0. It is considered that it was inside.
さらに実施例5において、アルコール濃度36.0vol%焼酎及びpH11.0調整溶液の混合液と脂肪酸エステル混和液から得られたO/W型エマルション1mlを、100mlのアルコール濃度36.0vol%焼酎に添加し、さらに割り水してアルコール濃度25.0vol%焼酎(C)を調製した。このアルコール濃度25.0vol%焼酎(C)を10人のパネラーに試飲してもらい、焼酎の香り、呈味の官能評価を行った。官能評価の結果を表8に示す。焼酎(C)は、コントロール焼酎(A)と比較して焼酎の油臭が低減し、甘味、とろみとコクが増したと評価された。 Further, in Example 5, 1 ml of an O / W type emulsion obtained from a mixed solution of alcohol concentration 36.0 vol% shochu and a pH 11.0 adjusted solution and a fatty acid ester mixed solution was added to 100 ml of alcohol concentration 36.0 vol% shochu. Then, the water was further divided to prepare an alcohol concentration of 25.0 vol% shochu (C). This alcohol concentration of 25.0 vol% shochu (C) was tasted by 10 panelists, and the aroma and taste of the shochu were sensory evaluated. The results of the sensory evaluation are shown in Table 8. It was evaluated that the shochu (C) had a reduced oily odor of the shochu and an increased sweetness, thickness and richness as compared with the control shochu (A).
実施例6では、表7に示す条件下で、アルコール飲料の一種である焼酎とpH11.0調整溶液の混合液を水相とするO/W型エマルションを調製した。水相に脂肪酸エステル混和液を添加し、ホモミキサーを使って24,000rpmで1分間撹拌乳化を行い、O/W型エマルションを室温25℃にて調製した後に、シラス多孔質ガラス膜(SPG膜;Shirasu Porous Glass、株式会社キヨモトテックイチ製)を用いて膜式分散処理したエマルションの安定性について検討した。 In Example 6, under the conditions shown in Table 7, an O / W type emulsion having a mixed solution of shochu, which is a kind of alcoholic beverage, and a pH 11.0 adjusted solution as an aqueous phase was prepared. A fatty acid ester admixture is added to the aqueous phase, and the mixture is stirred and emulsified at 24,000 rpm for 1 minute using a homomixer to prepare an O / W type emulsion at room temperature of 25 ° C. The stability of the emulsion subjected to the film-type dispersion treatment was investigated using (Shirasu Porous Glass, manufactured by Kiyomoto Techichi Co., Ltd.).
シラス多孔質ガラス(以下、「SPG」という。)を用いた乳化装置は、図10に示すように、上記したSPG膜モジュール1、窒素ガス2、分散相のタンク3、分散後相のタンク4から概ね構成され、分散相を加圧してSPG膜モジュール1に通過させることでエマルションを形成する。SPG膜の孔径は均一であり、分散後相の粒子径は均一なものとなる。
As shown in FIG. 10, the emulsification apparatus using Shirasu porous glass (hereinafter referred to as “SPG”) includes the above-mentioned SPG film module 1,
アルコール濃度36.0vol%焼酎とpH11.0調整溶液の混合液を水相とした。100mlの水相に1mlの脂肪酸エステル混和液を添加し、ホモミキサーを使って24,000rpmで1分間撹拌乳化をしてO/W型エマルションを室温25℃にて調製した。その後、SPG膜式乳化装置を用いて分散処理を施した。SPG膜透過時の圧力は4.0MPa、SPG膜の孔径は0.7μmを使用した。O/W型エマルションは調製直後、静置1時間、静置2時間及び静置24時間経過後に乳化状態の定性的な評価を行った。乳化状態の評価は、実施例1と同様に目視により行い、実施例4と同様に油滴の粒子径を測定して行った。 A mixed solution of alcohol concentration 36.0 vol% shochu and a pH 11.0 adjusted solution was used as an aqueous phase. A 1 ml fatty acid ester mixture was added to a 100 ml aqueous phase, and the mixture was stirred and emulsified at 24,000 rpm for 1 minute using a homomixer to prepare an O / W type emulsion at room temperature of 25 ° C. Then, the dispersion treatment was performed using the SPG membrane type emulsifying device. The pressure at the time of permeation of the SPG membrane was 4.0 MPa, and the pore size of the SPG membrane was 0.7 μm. Immediately after the preparation of the O / W type emulsion, the emulsified state was qualitatively evaluated after 1 hour of standing, 2 hours of standing and 24 hours of standing. The evaluation of the emulsified state was carried out visually in the same manner as in Example 1, and the particle size of the oil droplet was measured in the same manner as in Example 4.
アルコール濃度36.0vol%焼酎とpH11.0調整溶液の混合液に脂肪酸エステル混和液を添加して得られたO/W型エマルションをさらに、SPG膜により分散処理したところ、さらに安定したO/W型エマルションが得られた。SPG膜処理で得られたO/W型エマルションは、ホモミキサーで得られたO/W型エマルションより極めて均一であった(図11参照。)。その油滴の粒子径は0.568±0.073μmであった。 When the O / W type emulsion obtained by adding the fatty acid ester mixed solution to the mixed solution of alcohol concentration 36.0 vol% shochu and pH 11.0 adjusted solution was further dispersed by the SPG film, more stable O / W was obtained. A mold emulsion was obtained. The O / W type emulsion obtained by the SPG film treatment was much more uniform than the O / W type emulsion obtained by the homomixer (see FIG. 11). The particle size of the oil droplet was 0.568 ± 0.073 μm.
すなわち、実施例6では実施例5で得られたO/W型エマルションをさらにSPG膜を用いて分散処理したので、実施例5で調製したO/W型エマルションよりさらに油滴径が小さくなり、より安定的なO/W型エマルションを得られた。 That is, in Example 6, since the O / W type emulsion obtained in Example 5 was further dispersed using the SPG film, the oil droplet diameter was further smaller than that of the O / W type emulsion prepared in Example 5. A more stable O / W type emulsion was obtained.
実施例6において、アルコール濃度36.0vol%焼酎とpH11.0調整溶液の混合液に脂肪酸エステル混和液を添加して得られたO/W型エマルションをSPG膜により再分散処理したO/W型エマルション1mlを、100mlのアルコール濃度36.0vol%焼酎に添加し、さらに割り水してアルコール濃度25.0vol%焼酎(D)を調製した。このアルコール濃度25.0vol%焼酎(D)を10人のパネラーに試飲してもらい、焼酎の香り、呈味の官能評価を行った。官能評価の結果を表8に示す。焼酎(D)は、コントロール焼酎(A)と比較して焼酎の油臭はほぼ感じなくなり、甘香を強く感じ、甘味、とろみ、コクが増したと評価された。 In Example 6, an O / W type emulsion obtained by adding a fatty acid ester mixture to a mixed solution of alcohol concentration 36.0 vol% shochu and a pH 11.0 adjusted solution was redispersed with an SPG film. 1 ml of the emulsion was added to 100 ml of alcohol concentration 36.0 vol% shochu, and the mixture was further divided to prepare alcohol concentration 25.0 vol% shochu (D). This alcohol concentration of 25.0 vol% shochu (D) was tasted by 10 panelists, and the aroma and taste of the shochu were sensory evaluated. The results of the sensory evaluation are shown in Table 8. It was evaluated that the shochu (D) had almost no oily odor of the shochu, had a strong sweet scent, and had increased sweetness, thickening, and richness as compared with the control shochu (A).
表8に官能評価結果を示す。パネラーは10人、評価項目としては、香り(油臭、甘香)と味(油っぽさ、甘味、とろみ、コク、辛味及び渋み)についてコメントを得た。コメント欄の()内は人数である。評価対象は、焼酎(pH4.1)と脂肪酸エステル混和液の1,000rpmでの撹拌で得られたO/W型エマルションを添加したコントロール焼酎(A)、焼酎(pH4.1)と脂肪酸エステル混和液の24,000rpmでの撹拌で得られたO/W型エマルションを添加した焼酎(B)、焼酎及びpH11.0調整溶液の混合液と脂肪酸エステル混和液の24,000rpmでの撹拌で得られたO/W型エマルションを添加した焼酎(C)、焼酎及びpH11.0調整溶液の混合液と脂肪酸エステル混和液の24,000rpmでの撹拌で得られたO/W型エマルションにSPG膜で分散処理を施したものを添加した焼酎(D)の4品目とした。 Table 8 shows the sensory evaluation results. Ten panelists commented on the aroma (oil odor, sweet scent) and taste (oiliness, sweetness, thickening, richness, spiciness and astringency) as evaluation items. The number in parentheses in the comment section is the number of people. The evaluation targets were control shochu (A) to which an O / W type emulsion obtained by stirring a miscible solution of shochu (pH 4.1) and a fatty acid ester at 1,000 rpm was added, and miscibility with shochu (pH 4.1) and a fatty acid ester. It is obtained by stirring the O / W type emulsion-added shochu (B) obtained by stirring the liquid at 24,000 rpm, the mixed solution of shochu and the pH 11.0 adjusted solution, and the fatty acid ester mixed solution at 24,000 rpm. Disperse with an SPG film in the O / W type emulsion obtained by stirring the mixed solution of shochu (C), shochu and pH 11.0 adjusted solution to which the O / W type emulsion was added and the fatty acid ester mixed solution at 24,000 rpm. The four items of shochu (D) to which the treated product was added were used.
焼酎に添加したO/W型エマルション油滴の粒子径は、(A)が1.313±0.641μm、(B)が1.202±0.112μm、(C)が0.845±0.072μm、(D)が0.568±0.073μmであった。目視評価結果により、O/W型エマルション油滴の粒子径は、小さいほど安定的で官能評価が高かったことが示された。また、官能評価の結果、O/W型エマルション油滴の粒子径は、小さいほど焼酎の不良臭である油臭が低減し、風味が良好になったと考察される。したがって、SPG膜処理後のO/W型エマルションを添加した焼酎においては、著しい風味の向上があったと考察される。 The particle size of the O / W type emulsion oil droplets added to the shochu is 1.313 ± 0.641 μm for (A), 1.202 ± 0.112 μm for (B), and 0.845 ± 0. For (C). 072 μm and (D) were 0.568 ± 0.073 μm. From the visual evaluation results, it was shown that the smaller the particle size of the O / W type emulsion oil droplet, the more stable and the higher the sensory evaluation. Further, as a result of the sensory evaluation, it is considered that the smaller the particle size of the O / W type emulsion oil droplet is, the less the oily odor which is the bad odor of shochu, and the better the flavor. Therefore, it is considered that there was a significant improvement in flavor in the shochu to which the O / W type emulsion was added after the SPG film treatment.
尚、本発明における、本実施例では、O/W型エマルションを得るためにホモミキサーを使用しているが、乳化装置は特に限定されることはなく、例えば、一般用攪拌機、高速回転攪拌分散機、コロイドミル、加圧ノズル乳化機(均質機)、超音波乳化機、機械的振動攪拌機、静電場を利用した攪拌機などが挙げられ、その他乳化効果のあるものであればどのような乳化装置でもよい。 In the present embodiment of the present invention, a homomixer is used to obtain an O / W type emulsion, but the emulsifying device is not particularly limited, and for example, a general-purpose stirrer and high-speed rotary stirring dispersion are used. Machines, colloid mills, pressurized nozzle emulsifiers (homogenizers), ultrasonic emulsifiers, mechanical vibration stirrers, stirrers using electrostatic fields, etc. Any other emulsifying device that has an emulsifying effect. But it may be.
また、本発明に係るO/W型エマルションは、脂肪酸、脂溶性ビタミンEや脂溶性ポリフェノールなどの脂溶性物質は油相(O)に、水溶性ビタミンCや水溶性ポリフェノールなどの水溶性物質は水相(W)に添加することにより、このO/W型エマルションとO/W型エマルションを添加した食品、化粧品及び医薬組成物の風味調整、酸化防止、品質保持及び機能性の向上を図ることが可能となり得る。これらを検証するため、次の実施例7乃至実施例9にて実験を行った。 Further, in the O / W type emulsion according to the present invention, fat-soluble substances such as fatty acids, fat-soluble vitamin E and fat-soluble polyphenols are in the oil phase (O), and water-soluble substances such as water-soluble vitamin C and water-soluble polyphenols are in the oil phase (O). By adding to the aqueous phase (W), flavor adjustment, oxidation prevention, quality maintenance and improvement of functionality of foods, cosmetics and pharmaceutical compositions to which this O / W type emulsion and O / W type emulsion are added shall be aimed at. Can be possible. In order to verify these, experiments were carried out in the following Examples 7 to 9.
実施例7では、表9に示す条件下で、アルコール飲料の一種である焼酎とpH11.0調整溶液の混合液を水相とし、油相を脂肪酸エステル混和液に脂溶性ビタミンE溶液を添加した混合液(以下、「混合液油相(i)」という。)、又は脂溶性ポリフェノールであるβカロテン溶液を添加した混合液(以下、「混合液油相(ii)」という。)とするO/W型エマルションを調製した。これらについて、ホモミキサーを使って24,000rpmで1分間撹拌乳化を行い、O/W型エマルションを室温25℃にて調製した後に、SPG膜を用いて膜式分散処理した各エマルションの安定性について検討した。 In Example 7, under the conditions shown in Table 9, a mixed solution of shochu, which is a kind of alcoholic beverage, and a pH 11.0 adjusted solution was used as the aqueous phase, and the oil phase was added to the fatty acid ester mixed solution with the fat-soluble vitamin E solution. O as a mixed liquid (hereinafter referred to as "mixed liquid oil phase (i)") or a mixed liquid to which a β-carotene solution which is a fat-soluble polyphenol is added (hereinafter referred to as "mixed liquid oil phase (ii)"). / W type emulsion was prepared. About these, the stability of each emulsion which was subjected to the stirring emulsification at 24,000 rpm for 1 minute using a homomixer to prepare an O / W type emulsion at room temperature of 25 ° C., and then subjected to a film-type dispersion treatment using an SPG film. investigated.
アルコール濃度36.0vol%焼酎とpH11.0調整溶液の混合液を水相とした。100mlの水相に、脂肪酸エステル混和液と脂溶性ビタミンE溶液 (Covi−ox T−90(トコフェロール90%、大豆油10%);BASF Corporation製)の混合液油相(i)を1ml、及び脂肪酸エステル混和液と脂溶性ポリフェノールであるβカロテン溶液(β−カロテン30%懸濁液(β−カロテン30%、コーン油70%);DSM ニュートリション ジャパン株式会社製)の混合液油相(ii)を1mlそれぞれ添加し、ホモミキサーを使って24,000rpmで1分間撹拌乳化をしてO/W型エマルションを室温25℃にて調製した。その後、SPG膜処理装置を用いて分散処理を施した。SPG膜透過時の圧力は4.0MPa、SPG膜の孔径は0.7μmを使用した。O/W型エマルションは調製直後、静置1時間、静置2時間及び静置24時間経過後に、目視により乳化状態の定性的な評価を行った。エマルション評価方法は、実施例1と同様に目視評価方法と実施例4と同様に油滴の粒子径を測定した。
A mixed solution of alcohol concentration 36.0 vol% shochu and a pH 11.0 adjusted solution was used as an aqueous phase. 1 ml of a mixed liquid oil phase (i) of a fatty acid ester mixed solution and a fat-soluble vitamin E solution (Cobi-ox T-90 (tocopherol 90%,
これらをホモミキサーにより撹拌乳化処理した場合、さらに加えてSPG膜により分散処理した場合においても、共に安定的なO/W型エマルションが得られた。SPG膜処理で得られたO/W型エマルションは、ホモミキサーで得られたO/W型エマルションと比較して極めて均一な乳化状態が看取された。混合液油相(i)を添加したO/W型エマルションの油滴の粒子径については、ホモミキサー処理のみの場合は0.989±0.128μm、SPG膜処理を加えた場合は0.606±0.233μmであった。混合液油相(ii)を添加したO/W型エマルションの油滴の粒子径については、ホモミキサー処理のみの場合は0.863±0.114μm、SPG膜処理を加えた場合は0.557±0.149μmであった。 Both stable O / W type emulsions were obtained when these were stirred and emulsified with a homomixer and further dispersed with an SPG membrane. The O / W type emulsion obtained by the SPG film treatment was found to be in an extremely uniform emulsified state as compared with the O / W type emulsion obtained by the homomixer. The particle size of the oil droplets of the O / W type emulsion to which the mixed liquid oil phase (i) was added was 0.989 ± 0.128 μm when only the homomixer treatment was applied, and 0.606 when the SPG film treatment was added. It was ± 0.233 μm. The particle size of the oil droplets of the O / W type emulsion to which the mixed liquid oil phase (ii) was added was 0.863 ± 0.114 μm when only the homomixer treatment was applied, and 0.557 when the SPG film treatment was added. It was ± 0.149 μm.
実施例8では、表10に示す条件下で、アルコール飲料の一種である焼酎、pH11.0調整溶液にビタミンC溶液を添加した混合液(以下、「混合液水相(i)」という。)又はアントシアニン含有濃縮液を添加した混合液(以下、「混合液水相(ii)」という。)を各々水相とし、油相を脂肪酸エステル混和液とするO/W型エマルションを調製した。これらについて、ホモミキサーを使って24,000rpmで1分間撹拌乳化を行い、O/W型エマルションを室温25℃にて調製した後に、SPG膜を用いて膜式分散処理した各エマルションの安定性について検討した。 In Example 8, under the conditions shown in Table 10, a mixed solution of shochu, which is a kind of alcoholic beverage, and a vitamin C solution added to a pH 11.0 adjusted solution (hereinafter referred to as “mixed liquid aqueous phase (i)”). Alternatively, an O / W type emulsion was prepared in which the mixed solution to which the anthocyanin-containing concentrated solution was added (hereinafter referred to as “mixed solution aqueous phase (ii)”) was used as the aqueous phase, and the oil phase was used as the fatty acid ester mixed solution. About these, the stability of each emulsion which was subjected to the stirring emulsification at 24,000 rpm for 1 minute using a homomixer to prepare an O / W type emulsion at room temperature of 25 ° C., and then subjected to a film-type dispersion treatment using an SPG film. investigated.
アルコール濃度36.0vol%焼酎、pH11.0調整溶液及び水溶性ビタミンであるビタミンC(L−アスコルビン酸;東京化成工業株式会社製)溶液の混合液水相(i)、又は水溶性ポリフェノールであるアントシアニン含有濃縮液(有色甘藷アヤムラサキ濃縮汁KH;宮崎県農協果汁株式会社製)の混合液水相(ii)をそれぞれ100ml水相とした。100mlの各水相に、油相である脂肪酸エステル混和液1mlをそれぞれ添加し、ホモミキサーを使って24,000rpmで1分間撹拌乳化をしてO/W型エマルションを室温25℃にて調製した。その後、SPG膜処理装置を用いて分散処理を施した。SPG膜透過時の圧力は4.0MPa、SPG膜の孔径は0.7μmを使用した。O/W型エマルションは調製直後、静置1時間、静置2時間及び静置24時間経過後に、目視により乳化状態の定性的な評価を行った。エマルション評価方法は、実施例1と同様の目視と実施例4と同様に油滴の粒子径の測定により行った。 A mixed liquid aqueous phase (i) of alcohol concentration 36.0 vol% shochu, a pH 11.0 adjusted solution and a water-soluble vitamin C (L-ascorbic acid; manufactured by Tokyo Kasei Kogyo Co., Ltd.) solution, or a water-soluble polyphenol. The mixed liquid aqueous phase (ii) of the anthocyanin-containing concentrated solution (colored sweet potato Ayamurasaki concentrated juice KH; manufactured by Miyazaki Prefectural Agricultural Cooperative Fruit Juice Co., Ltd.) was taken as a 100 ml aqueous phase. To each 100 ml of the aqueous phase, 1 ml of a fatty acid ester admixture, which is an oil phase, was added, and the mixture was stirred and emulsified at 24,000 rpm for 1 minute using a homomixer to prepare an O / W type emulsion at room temperature of 25 ° C. .. Then, the dispersion treatment was performed using the SPG film treatment apparatus. The pressure at the time of permeation of the SPG membrane was 4.0 MPa, and the pore size of the SPG membrane was 0.7 μm. Immediately after preparation, the O / W type emulsion was visually evaluated qualitatively in an emulsified state after 1 hour of standing, 2 hours of standing, and 24 hours of standing. The emulsion evaluation method was carried out by visual inspection in the same manner as in Example 1 and measurement of the particle size of oil droplets in the same manner as in Example 4.
これらをホモミキサーにより撹拌乳化処理した場合、さらに加えてSPG膜により分散処理した場合においても、共に安定的なO/W型エマルションが得られた。SPG膜処理で得られたO/W型エマルションは、ホモミキサーで得られたO/W型エマルションと比較して極めて均一な乳化状態が看取された。混合液水相(i)を用いたO/W型エマルションの油滴の粒子径については、ホモミキサー処理のみの場合は0.822±0.120μm、SPG膜処理を加えた場合は0.455±0.119μmであった。混合液水相(ii)を用いたO/W型エマルションの油滴の粒子径については、ホモミキサー処理のみの場合は0.863±0.114μm、SPG膜処理を加えた場合は0.510±0.100μmであった。 Both stable O / W type emulsions were obtained when these were stirred and emulsified with a homomixer and further dispersed with an SPG membrane. The O / W type emulsion obtained by the SPG film treatment was found to be in an extremely uniform emulsified state as compared with the O / W type emulsion obtained by the homomixer. The particle size of the oil droplets of the O / W type emulsion using the mixed liquid aqueous phase (i) is 0.822 ± 0.120 μm when only the homomixer treatment is applied, and 0.455 when the SPG film treatment is added. It was ± 0.119 μm. The particle size of the oil droplets of the O / W type emulsion using the mixed liquid aqueous phase (ii) was 0.863 ± 0.114 μm when only the homomixer treatment was applied, and 0.510 when the SPG film treatment was added. It was ± 0.100 μm.
実施例9では、表11に示す条件下で、アルコール飲料の一種である焼酎、pH11.0調整溶液にビタミンC溶液を添加した混合液を水相とし、油相を脂肪酸エステル混和液に脂溶性ビタミンE溶液を添加した混合液とするO/W型エマルションを調製した。これらについて、ホモミキサーを使って24,000rpmで1分間撹拌乳化を行い、O/W型エマルションを室温25℃にて調製した後に、SPG膜を用いて膜式分散処理したエマルションの安定性について検討した。 In Example 9, under the conditions shown in Table 11, a mixed solution of shochu, which is a kind of alcoholic beverage, and a pH 11.0 adjusted solution to which a vitamin C solution is added is used as an aqueous phase, and the oil phase is fat-soluble in a fatty acid ester mixed solution. An O / W type emulsion was prepared as a mixed solution to which a vitamin E solution was added. These were subjected to stirring emulsification at 24,000 rpm for 1 minute using a homomixer to prepare an O / W type emulsion at room temperature of 25 ° C., and then the stability of the membrane-type dispersion-treated emulsion using an SPG film was examined. bottom.
アルコール濃度36.0vol%焼酎、pH11.0調整溶液及びビタミンC溶液の混合液を水相とした。100mlの水相に、油相である脂肪酸エステル混和液にビタミンE溶液を添加した混合液1mlを添加し、ホモミキサーを使って24,000rpmで1分間撹拌乳化をしてO/W型エマルションを室温25℃にて調製した。その後、SPG膜処理装置を用いて分散処理を施した。SPG膜透過時の圧力は4.0MPa、SPG膜の孔径は0.7μmを使用した。O/W型エマルションは調製直後、静置1時間、静置2時間及び静置24時間経過後に、目視により乳化状態の定性的な評価を行った。エマルション評価方法は、実施例1と同様の目視と実施例4と同様に油滴の粒子径の測定により行った。 A mixed solution of alcohol concentration 36.0 vol% shochu, pH 11.0 adjusted solution and vitamin C solution was used as an aqueous phase. To 100 ml of the aqueous phase, add 1 ml of a mixture of a fatty acid ester mixture, which is an oil phase, and a vitamin E solution, and use a homomixer to stir and emulsify at 24,000 rpm for 1 minute to form an O / W type emulsion. Prepared at room temperature 25 ° C. Then, the dispersion treatment was performed using the SPG film treatment apparatus. The pressure at the time of permeation of the SPG membrane was 4.0 MPa, and the pore size of the SPG membrane was 0.7 μm. Immediately after preparation, the O / W type emulsion was visually evaluated qualitatively in an emulsified state after 1 hour of standing, 2 hours of standing, and 24 hours of standing. The emulsion evaluation method was carried out by visual inspection in the same manner as in Example 1 and measurement of the particle size of oil droplets in the same manner as in Example 4.
これらをホモミキサーにより撹拌乳化処理した場合、さらに加えてSPG膜により分散処理した場合においても、共に安定的なO/W型エマルションが得られた。SPG膜処理で得られたO/W型エマルションは、ホモミキサーで得られたO/W型エマルションと比較して極めて均一な乳化状態が看取された。油滴の粒子径については、ホモミキサー処理は0.893±0.152μm、SPG膜処理は0.601±0.149μmであった。 Both stable O / W type emulsions were obtained when these were stirred and emulsified with a homomixer and further dispersed with an SPG membrane. The O / W type emulsion obtained by the SPG film treatment was found to be in an extremely uniform emulsified state as compared with the O / W type emulsion obtained by the homomixer. The particle size of the oil droplets was 0.893 ± 0.152 μm for the homomixer treatment and 0.601 ± 0.149 μm for the SPG membrane treatment.
実施例7乃至実施例9より、一般的に食品、化粧品及び医薬組成物の風味調整、酸化防止、品質保持及び機能性増進を目的として用いられる、脂肪酸、脂溶性ビタミンEやβカロテン、クルクミン、ルチン、イソフラボンなどの脂溶性ポリフェノールなどの脂溶性物質を油相(O)に、及び/又は水溶性ビタミンCやアントシアニン、クロロゲン酸、カフェ酸、カテキンなどの水溶性ポリフェノールなどの水溶性物質を水相(W)に添加してO/W型エマルションを調製しても、乳化安定性に影響を及ぼさないことが分かった。 From Examples 7 to 9, fatty acids, fat-soluble vitamin E, β-carotene, and curcumin, which are generally used for the purpose of flavor adjustment, antioxidant, quality maintenance, and functional enhancement of foods, cosmetics, and pharmaceutical compositions. Water-soluble substances such as fat-soluble polyphenols such as rutin and isoflavone are used in the oil phase (O), and / or water-soluble substances such as water-soluble polyphenols such as water-soluble vitamin C, anthocyanin, chlorogenic acid, caffeic acid, and catechin are added to water. It was found that even if it was added to the phase (W) to prepare an O / W type emulsion, it did not affect the emulsion stability.
本発明の要旨は、界面活性剤、乳化剤及び/又は酵素剤などを使用することなく、経済的に簡便かつより純粋なアルコール溶液と脂肪酸エステルのO/W型エマルションを得ることにある。すなわち、界面活性剤、乳化剤及び/又は酵素剤などを使用しないので、素材の持つ純粋な物性や機能性を保持することができ、安全性を要する食品、医薬組成物又は化粧品に用いて有効である。 The gist of the present invention is to obtain an economically simple and more pure alcohol solution and an O / W type emulsion of a fatty acid ester without using a surfactant, an emulsifier and / or an enzyme agent. That is, since no surfactant, emulsifier and / or enzyme agent is used, the pure physical characteristics and functionality of the material can be maintained, and it is effective for use in foods, pharmaceutical compositions or cosmetics requiring safety. be.
例えば、O/W型エマルション溶液を含有する食品(ドレッシング、調理酒、味醂などの調味料、芋焼酎、米焼酎、麦焼酎、そば焼酎、黒糖焼酎、スピリッツ、リキュール、ウイスキー、果実酒、薬用酒、薬味酒などの酒類、ドリンク剤、カプセル剤、ホルモン剤、ビタミン剤、滋養強壮ドリンク剤などの健康栄養剤等が挙げられる。)、医薬組成物(薬用酒、貼付剤、ゲル剤、軟膏剤、クリーム剤等が挙げられる。)又は化粧品(化粧水、乳液、保湿液、美容液、クリーム、日やけ止め、洗顔液、爪化粧料、整髪料、育毛料、養毛料等が挙げられる。)に用いて有用である。 For example, foods containing O / W type emulsion solution (dressing, cooked liquor, seasonings such as miso, potato liquor, rice liquor, barley liquor, buckwheat liquor, brown sugar liquor, spirits, liqueur, whiskey, fruit liquor, medicated liquor. , Alcoholic beverages such as medicinal liquor, drinks, capsules, hormones, vitamins, health nutritional supplements such as nourishing tonic drinks, etc.), pharmaceutical compositions (medicinal liquor, patches, gels, ointments) , Creams, etc.) or cosmetics (including lotions, milky lotions, moisturizers, beauty liquids, creams, sunscreens, facial cleansers, nail cosmetics, hairdressing agents, hair growth agents, hair growth agents, etc.) It is useful to use in.
すなわち、本発明のO/W型エマルションは水相(W)のアルコール濃度を低濃度から高濃度までに幅広く適用でき、多岐にわたる食品、医薬組成物又は化粧品に提供することができる。 That is, the O / W type emulsion of the present invention can widely apply the alcohol concentration of the aqueous phase (W) from a low concentration to a high concentration, and can be provided for a wide variety of foods, pharmaceutical compositions or cosmetics.
本発明は、脂肪酸エステルなどに起因する指摘不良臭を改善でき、これを含有する食品、医薬組成物又は化粧品の風味又は香りの改善効果が期待できる。 INDUSTRIAL APPLICABILITY The present invention can improve the indicated bad odor caused by fatty acid esters and the like, and can be expected to have an effect of improving the flavor or aroma of foods, pharmaceutical compositions or cosmetics containing the same.
本発明によれば、産業廃棄物の脂肪酸エステル(例えば、焼酎製造中に冷却ろ過により除去された不良臭を持つ油性成分)の再利用を可能にする。つまり、当該脂肪酸エステルのO/W型エマルションを調製し、当該エマルションを含有する食品(焼酎、スピリッツ、リキュール、ドレッシング、ドリンク剤、カプセル剤、栄養機能食品などが挙げられる)、医薬組成物(薬用酒、軟膏剤、クリーム剤などが挙げられる)又は化粧品(育毛剤、乳液、保湿液、美容液、クリームなどが挙げられる)の風味改善及び調整あるいは機能性の改善及び調整を図ることができる。 According to the present invention, it is possible to reuse fatty acid esters of industrial waste (for example, oily components having a bad odor removed by cooling filtration during the production of shochu). That is, an O / W type emulsion of the fatty acid ester is prepared, and foods containing the emulsion (including shochu, spirits, liqueur, dressings, drinks, capsules, nutritionally functional foods, etc.), pharmaceutical compositions (medicinal). The flavor can be improved and adjusted, or the functionality can be improved and adjusted, such as alcohol, ointments, creams, etc.) or cosmetics (hair growth agents, emulsions, moisturizers, beauty essences, creams, etc.).
1 SPG膜モジュール
2 窒素ガス
3 分散相のタンク
4 分散後相のタンク
1
Claims (9)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2019144069A JP6969037B2 (en) | 2019-08-05 | 2019-08-05 | Alcohol-containing O / W emulsion and its manufacturing method |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2019144069A JP6969037B2 (en) | 2019-08-05 | 2019-08-05 | Alcohol-containing O / W emulsion and its manufacturing method |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2021023214A JP2021023214A (en) | 2021-02-22 |
| JP6969037B2 true JP6969037B2 (en) | 2021-11-24 |
Family
ID=74661893
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019144069A Active JP6969037B2 (en) | 2019-08-05 | 2019-08-05 | Alcohol-containing O / W emulsion and its manufacturing method |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JP6969037B2 (en) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR102695644B1 (en) * | 2021-01-25 | 2024-08-21 | 주식회사 노즈워크 | Paste composition for companion animals and method thereof |
| CN117562241A (en) * | 2023-12-29 | 2024-02-20 | 乐凯华光印刷科技有限公司 | Preparation method of water-soluble capsicum oleoresin, prepared water-soluble capsicum oleoresin and application thereof |
| CN121312809A (en) * | 2025-11-04 | 2026-01-13 | 中国农业科学院农业环境与可持续发展研究所 | A Coenzyme Q10-based Multiple Nanoemulsion, its Preparation Method and Application |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4835002A (en) * | 1987-07-10 | 1989-05-30 | Wolf Peter A | Microemulsions of oil in water and alcohol |
| JP3285831B2 (en) * | 1989-09-21 | 2002-05-27 | 薩摩酒造株式会社 | Production method of muddy shochu |
| JP3100142B2 (en) * | 1989-09-21 | 2000-10-16 | 薩摩酒造株式会社 | Production method of muddy shochu |
| JP3116028B2 (en) * | 1997-11-21 | 2000-12-11 | 東五 黒岩 | Shochu distillation method |
-
2019
- 2019-08-05 JP JP2019144069A patent/JP6969037B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| JP2021023214A (en) | 2021-02-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP1902633B1 (en) | Method for preparing solubilized composition containing oil-soluble substance | |
| JP4563438B2 (en) | Transparent emulsified composition and transparent emulsified fragrance composition for alcoholic beverage or carbonated beverage | |
| JP6969037B2 (en) | Alcohol-containing O / W emulsion and its manufacturing method | |
| JP5588048B1 (en) | Emulsified fragrance composition | |
| JP5787371B2 (en) | Emulsified composition, method for producing the same, and food and drink containing the same | |
| KR101116899B1 (en) | Concentrated and diluted stable oil/water emulsions | |
| WO2018235848A1 (en) | Emulsified composition and beverage | |
| JPWO2008004509A1 (en) | Squalene-containing oily composition and squalene-containing oil-in-water emulsion | |
| WO2018190203A1 (en) | Antioxidant dispersion | |
| JP2741093B2 (en) | Production method of emulsion composition for food and drink | |
| JP2009207384A (en) | Emulsion composition for coenzyme q10-containing beverage, and method for producing the same | |
| JP5288407B2 (en) | O / W emulsified composition of oil-soluble substance | |
| EP3677121A1 (en) | Fat or oil composition containing unsaturated fatty acid | |
| WO2021122414A1 (en) | Flavor compositions for beverage and personal care applications | |
| WO2018061723A1 (en) | Premix for preparing emulsion composition, and composition using same | |
| JP2008143841A (en) | Composition containing highly crystalline substance | |
| JP3145579B2 (en) | Powdering method for edible oily material | |
| JP5358811B2 (en) | Noodle loosening agent and method for improving noodle loosening | |
| JP4887351B2 (en) | Isothiocyanate emulsion composition | |
| FR2754193A1 (en) | Reducing viscosity of aqueous sucrose fatty ester solution | |
| JP7675486B2 (en) | Method for producing yogurt containing DHA | |
| WO2007046333A1 (en) | Emulsifying agent and emulsion composition prepared with the same | |
| JP2009095277A (en) | Beverage production method | |
| JP4670008B2 (en) | Additives for rice cooking containing higher aliphatic compounds | |
| JP2004189749A (en) | Cosmetic composition |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20190805 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20200901 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20201030 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20210302 |
|
| A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20210416 |
|
| RD02 | Notification of acceptance of power of attorney |
Free format text: JAPANESE INTERMEDIATE CODE: A7422 Effective date: 20210510 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A821 Effective date: 20210511 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20210701 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20210715 |
|
| TRDD | Decision of grant or rejection written | ||
| A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20210817 |
|
| A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20210906 |
|
| R150 | Certificate of patent or registration of utility model |
Ref document number: 6969037 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |